Safety and efficacy of human serum albumin treatment in patients with cirrhotic ascites undergoing paracentesis: A systematic review and meta-analysis

array:24 ["pii" => "S1665268121002465" "issn" => "16652681" "doi" => "10.1016/j.aohep.2021.100547" "estado" => "S300" "fechaPublicacion" => "2021-12-01" "aid" => "100547" "copyright" => "Fundación Clínica Médica Sur, A.C." "copyrightAnyo" => "2021" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "rev" "cita" => "Ann Hepatol. 2021;26C:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:18 [ "pii" => "S1665268121002337" "issn" => "16652681" "doi" => "10.1016/j.aohep.2021.100534" "estado" => "S300" "fechaPublicacion" => "2021-12-01" "aid" => "100534" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "rev" "cita" => "Ann Hepatol. 2021;26C:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "Concise review" "titulo" => "Alternative splicing and liver disease" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0003" "etiqueta" => "Fig. 3." "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 1266 "Ancho" => 2925 "Tamanyo" => 170461 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0003" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Diagram exemplifying how alteration of SRSF3 can result in liver pathologies. (A) hepatic fibrosis/ liver inflammation reduces the expression levels of SRSF3 via neddylation. Decreased SRSF3 expression in the nucleus (blue circle with dotted circumference) affects the inclusion or exclusion of hundreds of exons, a few, of which are known to be central to NAFLD, NASH, and liver cirrhosis liver are indicated. (B) Hepatocyte growth factor, binding to hepatocyte growth factor receptor (C-Met), induces the PI3K/Akt signaling pathway to decrease SRSF3 levels. The decrease in SRSF3 levels results in an alternative splicing event within the SRSF1 gene producing an isoform that undergoes nonsense-mediated decay. This results in a decreased in SRSF1 expression. Low expression of SRSF1 in the nucleus produces a variety of alterations in the splicing events among which that of the tumor suppressor Kruppel-like factor 6 (KLF6), enhancing the splicing pattern SV1 isoform <a class="elsevierStyleCrossRef" href="#bib0066">[66]</a>, which leads to increased cell proliferation as it antagonizes the ability of wild-type KLF6 to suppress it." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Marco Baralle, Francisco. E. Baralle" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Marco" "apellidos" => "Baralle" ] 1 => array:2 [ "nombre" => "Francisco. E." "apellidos" => "Baralle" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268121002337?idApp=UINPBA00004N" "url" => "/16652681/000000260000000C/v5_202208200714/S1665268121002337/v5_202208200714/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S1665268121002568" "issn" => "16652681" "doi" => "10.1016/j.aohep.2021.100557" "estado" => "S300" "fechaPublicacion" => "2021-12-01" "aid" => "100557" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "rev" "cita" => "Ann Hepatol. 2021;26C:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "Concise reviews" "titulo" => "Pregnancy in Chronic Liver Disease: Before and After Transplantation" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Amr Dokmak, Hirsh D. Trivedi, Alan Bonder, Jacqueline Wolf" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Amr" "apellidos" => "Dokmak" ] 1 => array:2 [ "nombre" => "Hirsh D." "apellidos" => "Trivedi" ] 2 => array:2 [ "nombre" => "Alan" "apellidos" => "Bonder" ] 3 => array:2 [ "nombre" => "Jacqueline" "apellidos" => "Wolf" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268121002568?idApp=UINPBA00004N" "url" => "/16652681/000000260000000C/v5_202208200714/S1665268121002568/v5_202208200714/en/main.assets" ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "Concise review" "titulo" => "Safety and efficacy of human serum albumin treatment in patients with cirrhotic ascites undergoing paracentesis: A systematic review and meta-analysis" "tieneTextoCompleto" => true "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Dhan Bahadur Shrestha, Pravash Budhathoki, Yub Raj Sedhai, Ramkaji Baniya, Shila Awal, Jashpal Yadav, Lila Awal, Brian Davis, Markos G. Kashiouris, Casey A. Cable" "autores" => array:10 [ 0 => array:4 [ "nombre" => "Dhan Bahadur" "apellidos" => "Shrestha" "email" => array:1 [ 0 => "medhan75@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0001" ] 1 => array:2 [ "etiqueta" => "1" "identificador" => "fn1" ] ] ] 1 => array:4 [ "nombre" => "Pravash" "apellidos" => "Budhathoki" "email" => array:1 [ 0 => "pravash.budhathoki123@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0002" ] 1 => array:2 [ "etiqueta" => "2" "identificador" => "fn2" ] ] ] 2 => array:4 [ "nombre" => "Yub Raj" "apellidos" => "Sedhai" "email" => array:1 [ 0 => "YubRaj.Sedhai@vcuhealth.org" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "c" "identificador" => "aff0003" ] 1 => array:2 [ "etiqueta" => "3" "identificador" => "fn3" ] 2 => array:2 [ "etiqueta" => "*" "identificador" => "cor0001" ] ] ] 3 => array:4 [ "nombre" => "Ramkaji" "apellidos" => "Baniya" "email" => array:1 [ 0 => "rbaniya.md@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "d" "identificador" => "aff0004" ] 1 => array:2 [ "etiqueta" => "4" "identificador" => "fn4" ] ] ] 4 => array:4 [ "nombre" => "Shila" "apellidos" => "Awal" "email" => array:1 [ 0 => "shila.awal@naihs.edu.np" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "e" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "5" "identificador" => "fn5" ] ] ] 5 => array:4 [ "nombre" => "Jashpal" "apellidos" => "Yadav" "email" => array:1 [ 0 => "jashpal.yadav@naihs.edu.np" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "e" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "6" "identificador" => "fn6" ] ] ] 6 => array:4 [ "nombre" => "Lila" "apellidos" => "Awal" "email" => array:1 [ 0 => "lilaawal1998@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "f" "identificador" => "aff0006" ] 1 => array:2 [ "etiqueta" => "7" "identificador" => "fn7" ] ] ] 7 => array:4 [ "nombre" => "Brian" "apellidos" => "Davis" "email" => array:1 [ 0 => "Brian.Davis1@vcuhealth.org" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "g" "identificador" => "aff0007" ] 1 => array:2 [ "etiqueta" => "8" "identificador" => "fn8" ] ] ] 8 => array:4 [ "nombre" => "Markos G." "apellidos" => "Kashiouris" "email" => array:1 [ 0 => "Markos.Kashiouris@vcuhealth.org" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "h" "identificador" => "aff0008" ] 1 => array:2 [ "etiqueta" => "9" "identificador" => "fn9" ] ] ] 9 => array:4 [ "nombre" => "Casey A." "apellidos" => "Cable" "email" => array:1 [ 0 => "Casey.Cable@vcuhealth.org" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "h" "identificador" => "aff0008" ] 1 => array:2 [ "etiqueta" => "10" "identificador" => "fn10" ] ] ] ] "afiliaciones" => array:8 [ 0 => array:3 [ "entidad" => "Department of Internal Medicine, Mount Sinai Hospital, Chicago, IL, USA" "etiqueta" => "a" "identificador" => "aff0001" ] 1 => array:3 [ "entidad" => "Department of Internal Medicine, BronxCare Health System, Bronx, NY, USA" "etiqueta" => "b" "identificador" => "aff0002" ] 2 => array:3 [ "entidad" => "Department of Internal Medicine, Division of Hospital Medicine, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA" "etiqueta" => "c" "identificador" => "aff0003" ] 3 => array:3 [ "entidad" => "Department of Internal Medicine, Our Lady of the Lake Regional Medical Center; Baton Rouge, LA, USA" "etiqueta" => "d" "identificador" => "aff0004" ] 4 => array:3 [ "entidad" => "Nepalese Army Institute of Health Sciences, Kathmandu, Nepal" "etiqueta" => "e" "identificador" => "aff0005" ] 5 => array:3 [ "entidad" => "Rangpur Medical College, Rangpur, Bangladesh" "etiqueta" => "f" "identificador" => "aff0006" ] 6 => array:3 [ "entidad" => "Department of Internal Medicine, Division of Gastroenterology, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA" "etiqueta" => "g" "identificador" => "aff0007" ] 7 => array:3 [ "entidad" => "Department of Pulmonary Disease and Critical Care Medicine, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA" "etiqueta" => "h" "identificador" => "aff0008" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0001" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0006" "etiqueta" => "Fig. 6" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr6.jpeg" "Alto" => 1836 "Ancho" => 3583 "Tamanyo" => 564164 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0006" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Forest plot showing hospital readmission comparing albumin with other therapy using fixed effect model." ] ] ] "textoCompleto" => "1IntroductionAscites is the most common presentation of decompensated cirrhosis and is associated with complications like spontaneous bacterial peritonitis and 50% mortality at 2 years <a class="elsevierStyleCrossRef" href="#bib0001">[1]</a>. It produces symptoms including abdominal distension, abdominal discomfort, dyspnea, and spontaneous bacterial peritonitis often necessitating hospitalization [<a class="elsevierStyleCrossRef" href="#bib0002">2</a>,<a class="elsevierStyleCrossRef" href="#bib0003">3</a>]. Therapeutic paracentesis is the first line of treatment for patients with tense (i.e., grade 3) and refractory ascites <a class="elsevierStyleCrossRef" href="#bib0004">[4]</a>. Patients with liver disease have altered circulatory physiology, with splanchnic arteriolar vasodilation, hyperdynamic circulation, and decreased effective arterial blood volume. It is also associated with activation of the renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system (SNS), along with an increased antidiuretic hormone levels and sodium and water retention. Paracentesis substantially influences hemodynamics in an already altered physiological state <a class="elsevierStyleCrossRef" href="#bib0005">[5]</a>. Therapeutic paracentesis especially large-volume paracentesis (LVP) is associated with paracentesis-induced circulatory dysfunction (PICD) which is defined as a 50% increase in plasma renin activity (PRA) over the baseline on the sixth day after treatment, up to a value > 4 ng/mL per hour <a class="elsevierStyleCrossRef" href="#bib0006">[6]</a>.The role of adjunctive albumin infusion in preventing PICD after LVP has been studied since the 1980s <a class="elsevierStyleCrossRef" href="#bib0002">[2]</a>. Guidelines dealing with the management of ascites vary in their recommendations. The current European Association for the Study of the Liver (EASL) guideline (2016) recommends the infusion of human albumin after paracentesis, regardless of volume, although emphasizing the need for its substitution after a drained volume of 5 L or more. While the American Association for the Study of Liver Diseases (AASLD) guideline (2013) recommends albumin infusion after a paracentesis of 5 L or more, however, may not be necessary for a single paracentesis of less than 4–5L [<a class="elsevierStyleCrossRef" href="#bib0007">7</a>,<a class="elsevierStyleCrossRef" href="#bib0008">8</a>].It is worthwhile to note the limited availability and a worldwide shortage of albumin. Albumin is extracted from human serum, although having fewer side effects, does carry a theoretical risk of transmission of diseases. Although the cost varies globally, considering the amount of albumin required after paracentesis to meet demands per guidelines (6–8 g/L of fluid removal) makes albumin therapy after paracentesis an expensive intervention. Cost-effective alternatives to albumins like artificial colloid volume expanders and vasoconstrictors have been investigated. Despite numerous randomized trials, it remains uncertain whether the effectiveness of such alternative treatments is comparable to that of albumin. This uncertainty, partly, reflects the limited statistical power of the randomized trials. Quantitatively combining results of all relevant trials by meta‐analysis could help in resolving the uncertainty. Most recently a meta-analysis by Kütting et al. (2016) failed to show benefit in clinical endpoints including mortality <a class="elsevierStyleCrossRef" href="#bib0009">[9]</a>. Furthermore, two large randomized controlled trials have been published since 2016 [<a class="elsevierStyleCrossRef" href="#bib0010">10</a>,<a class="elsevierStyleCrossRef" href="#bib0011">11</a>]. Thus, to fully appraise the available data, we sought to perform this systematic review and meta-analysis including 21 trials in 1584 patients with cirrhotic ascites.2MethodsWe used PRISMA for the systemic review of available literature <a class="elsevierStyleCrossRef" href="#bib0012">[12]</a>. Our meta-analysis protocol was registered in Prospero (CRD42020223464) <a class="elsevierStyleCrossRef" href="#bib0013">[13]</a>.2.1Types of studiesAll randomized controlled trials (RCTs) published till 18 May 2021 comparing efficacy and safety of human albumin with other volume expanders and vasoactive agents following paracentesis in patients with ascites due to cirrhosis were included. Non-RCTs, Editorials, Commentaries, Viewpoint articles with no proper data of human albumin treatment in patients with ascites due to cirrhosis were excluded.2.2Types of participantThe study included all the adult patients (≥ 18 years old) diagnosed with tense and/or refractory ascites due to cirrhosis.2.3Types of interventionWe included studies where human serum albumin was administered following paracentesis in the patients with tense and/or refractory ascites due to cirrhosis.2.4ComparatorComparators were placebo, standard care of management (diuretic therapy, and sodium restriction, and use of vasoconstrictors or other volume expanders after therapeutic paracentesis).2.5Types of outcome measuresOur outcomes were incidence of paracentesis induced circulatory dysfunction, mortality, mean arterial pressure (MAP) at 3–4 days of treatment, hyponatremia, the reappearance of ascites, hospital readmission, and complications like hepatic encephalopathy, renal impairment, and gastrointestinal bleeding.2.6Search methods for identification of studiesPublished papers were screened by two authors based on inclusion and exclusion criteria using Covidence <a class="elsevierStyleCrossRef" href="#bib0014">[14]</a>. Any possible conflicts were resolved by a third member.2.6.1Electronic searchesWe have included the electronic search strategy in Supplementary file 1.2.6.2Data collection and analysisDatabases like PubMed, PMC, Scopus, and Embase were searched using appropriate Boolean with no language restriction. We extracted the data onto a standardized form designed in Microsoft Excel-13.2.6.3Selection of studiesWe included studies comparing the efficacy and safety of human albumin treatment with outcomes of our interest in patients with ascites due to cirrhosis following paracentesis. We included studies that had both treatment and control groups. The treatment group was comprised of patients with liver cirrhosis and ascites who were treated with albumin after paracentesis and the control group was comprised of patients with liver cirrhosis and ascites who received paracentesis followed by standard medical treatments either placebo or vasoconstrictors or other volume expanders. Editorials, Commentaries, Viewpoint articles with no proper data of human albumin treatment in patients with ascites due to cirrhosis were excluded.2.7Data extraction and managementWe evaluated the quality of studies and included the outcome in the qualitative and quantitative synthesis.2.7.1Assessment of risk of bias in included studiesWe used Cochrane ROB 2.0 to assess the risk of bias for Trials (<a class="elsevierStyleCrossRef" href="#fig0001">Fig. 1</a>.) <a class="elsevierStyleCrossRef" href="#bib0015">[15]</a>.<elsevierMultimedia ident="fig0001"></elsevierMultimedia>2.7.2Assessment of heterogeneityWe assessed the heterogeneity using the I-squared (I2) test. We used the Cochrane Handbook for Systematic Reviews of Interventions for interpretation of I2 test done as follows based on 0–40%: might not be important; 30–60% may represent moderate heterogeneity; 50–90%: may represent substantial heterogeneity; 75% to 100%: considerable heterogeneity <a class="elsevierStyleCrossRef" href="#bib0016">[16]</a>. The importance of the observed value of I2 depends on the magnitude and direction of effects and the strength of evidence for heterogeneity.2.7.3Data synthesisRevMan 5.4 was used for data synthesis <a class="elsevierStyleCrossRef" href="#bib0017">[17]</a>. Odds ratio (OR) and mean difference was used to estimate the outcome with a 95% confidence interval (CI) where appropriate, and heterogeneity was measured using I²-test. We analyzed the mean difference between two groups, one receiving albumin and the other receiving other treatment for an outcome like mean arterial pressure after 3–4 days of treatment <a class="elsevierStyleCrossRef" href="#bib0018">[18]</a>. Further sensitivity analysis was performed based on time-frame (studies published before 2000 vs. after 2000) for main outcomes (PICD, mortality, MAP, and hyponatremia).3ResultsWe identified 19482 studies after thorough database searching. After the removal of 3543 duplicates, we screened the title and abstract of 15939 studies and excluded 15823 studies. A total of 116 studies were assessed for full-text eligibility and we excluded 95 studies with definite reasons (<a class="elsevierStyleCrossRef" href="#fig0002">Fig. 2</a>). We included 21 studies in our qualitative and quantitative analysis (<a class="elsevierStyleCrossRef" href="#tbl0001">Table 1</a>). Basic features of included studies are presented in Supplementary file 2 (Tables 1 and 2).<elsevierMultimedia ident="fig0002"></elsevierMultimedia><elsevierMultimedia ident="tbl0001"></elsevierMultimedia>3.1Quantitative synthesisA total of 21 RCTs in 1584 patients were included in the analysis.3.1.1Paracentesis induced circulatory dysfunction (PICD)Nine RCTs reported PICD as an outcome in their study. Overall use of albumin has reduced the odds of PICD by 60% (OR 0.40, 95% CI 0.27–0.58; n = 729; I2 = 0%). Further analysis showed albumin was superior to other volume expanders in terms of reducing PICD (OR 0.34, 95% CI 0.22–0.52; n = 606; I2 =0%), while comparing albumin with vasoconstrictor therapy did not reach statistical significance (OR 0.93, 95% CI 0.35–2.45; n = 123; I2 =0%) (<a class="elsevierStyleCrossRef" href="#fig0003">Fig. 3</a>.).<elsevierMultimedia ident="fig0003"></elsevierMultimedia>Further pooling of data on PICD based on time frame using fixed effect model showed significant reduction in odds of PICD in albumin group among studies published before 2000 (OR 0.32, 95% CI 0.19–0.54; n = 364; I2 =43%), and after 2000 (OR 0.50, 95% CI 0.29–0.87; n = 365; I2 =0%) (Supplementary file 3, Fig. 1).3.1.2Mortality outcomeThirteen studies reported the mortality as an outcome during the study period and follow up. Analysis showed some reduction in overall odds of mortality using albumin therapy but did not reach statistical significance (OR 0.72, 95% CI 0.50–1.03; n = 1129; I2 =0%). Further analysis comparing albumin therapy with vasoconstrictor agents (OR 0.84, 95% CI 0.26–2.67; n = 140; I2 =0%) and placebo or standard medical therapy (SMT) (OR 1.26, 95% CI 0.61–2.57; n = 218; I2 =0%) showed no significant differences of using albumin therapy over others. But, use of albumin showed a 43% lower odds of mortality compared to other volume expanders (OR 0.57, 95% CI 0.36–0.89; n = 771; I2 =0%) (<a class="elsevierStyleCrossRef" href="#fig0004">Fig. 4</a>).<elsevierMultimedia ident="fig0004"></elsevierMultimedia>Further pooling of data on the mortality outcome during the study period and follow up based on time frame using fixed effect model showed some reduction in mortality in the albumin group but it could not reach the level of significance among studies published before 2000 (OR 0.78, 95% CI 0.50–1.23; n = 618; I2 =0%), and after 2000 (OR 0.64, 95% CI 0.36–1.13; n = 511; I2 =0%) (Supplementary file 3, Fig. 2).3.1.3Re-appearance of ascitesAnalysis from pooled data from 5 studies showed no significant reduction in the reappearance of ascites in albumin-treated patients compared to patients receiving other interventions (OR 0.82, 95% CI 0.51–1.32; n = 392; I2 =0%) (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 5</a>)<elsevierMultimedia ident="fig0005"></elsevierMultimedia>3.1.4Hospital readmissionPooling data from seven studies showed that the use of albumn therapy did not reach statistical significance for hospital readmission while comparing with other therapies (OR 0.75, 95% CI 0.54–1.05; n = 591; I2 =0%). Comparing albumin therapy with other volume expanders (OR 0.79, 95% CI 0.53–1.17; n = 414; I2 =0%), and SMT (OR 0.67, 95% CI 0.36–1.25; n = 177; I2 =0%) did not show a significant reduction in readmission either (<a class="elsevierStyleCrossRef" href="#fig0006">Fig. 6</a>).<elsevierMultimedia ident="fig0006"></elsevierMultimedia>3.1.5Mean arterial pressure (MAP) after 4–6 days of therapyAnalysis taking data of 18 studies reporting MAP did not show significant differences in MAP between albumin and other treatment groups (MD -0.06, 95% CI -1.23 to 1.10; n = 1194; I2 =93%). Further analysis considering type of the control therapy also did not show significant differences in MAP among albumin group over other volume expanders (MD 0.32, 95% CI -1.23 to 1.86; n = 787; I2 =93%); vasoconstrictor agents use (MD 1.02, 95% CI -0.58 to 2.62; n = 174; I2 =0%); and SMT (MD -1.37, 95% CI -7.48 to 4.73; n = 233; I2 =97%) (<a class="elsevierStyleCrossRef" href="#fig0007">Fig. 7</a>).<elsevierMultimedia ident="fig0007"></elsevierMultimedia>Further pooling of data in MAP based on time frame using random-effect model among studies published before 2000 showed no significant differences in MAP between albumin and other treatment groups (MD -1.41, 95% CI -3.28 to 0.45; n = 594; I2 =95%), however among studies published after 2000 there were some but significantly higher MAP after 4–6 days of therapy in albumin group (MD 1.82, 95% CI 1.44 to 2.20; n = 600; I2 =0%) (Supplementary file 3, Fig. 3).3.1.6HyponatremiaAmong 13 studies reporting hyponatremia outcome, pooling of the data showed overall significant low incidence of hyponatremia among albumin treated group than other treatment (OR 0.59, 95% CI 0.39–0.88; n = 1058; I2 =0%). On further analysis, there was significant reduction of incidence of hyponatremia in patients recieving albumin therapy as compared to SMT (OR 0.24, 95% CI 0.08–0.74; n = 212; I2 =0%), but was not statistically significant while comparing with volume expanders (OR 0.66, 95% CI 0.41–1.06; n = 763; I2 =0%) or vasopressor group (OR 0.92, 95% CI 0.27–3.11; n = 83; I2 =0%) (<a class="elsevierStyleCrossRef" href="#fig0008">Fig. 8</a>.).<elsevierMultimedia ident="fig0008"></elsevierMultimedia>Further pooling of data for hyponatremia outcome based on time frame using fixed effect model among studies published before 2000 showed significantly lower incidence of hyponatremia among albumin treated group than other treatment (OR 0.57, 95% CI 0.35–0.93; n = 672; I2 =0%), however, among studies published after 2000, there was some lower odds of hyponatremia in albumin group but could not reach the level of significance (OR 0.63, 95% CI 0.30–1.32; n = 386; I2 =0%) (Supplementary file 3, Fig. 4).3.1.7Renal impairmentOverall incidence of renal impairment was not statistically significant between albumin and other therapy (OR 0.76, 95% CI 0.46–1.25; n = 1048; I2 =0%). On further analysis, there was no significant reduction in incidence of renal impairment in patients treated with albumin as compared with other volume expanders (OR 1.06, 95% CI 0.59–1.92; n = 771; I2 =0%), and SMT (OR 1.57, 95% CI 0.55–4.47; n = 181; I2 =0%) (<a class="elsevierStyleCrossRef" href="#fig0009">Fig. 9</a>.).<elsevierMultimedia ident="fig0009"></elsevierMultimedia>3.1.8Hepatic encephalopathy (HE)Overall hepatic encephalopathy incidence among albumin and other treatment group was reported in ten studies. Pooling of the data showed no significant differences among albumin and other treatment for incidence of HE (OR 1.05, 95% CI 0.62–1.77; n = 916; I2 =0%). Further contrasting albumin with other volume expanders (OR 0.91, 95% CI 0.49–1.67; n = 735; I2 =0%), and SMT (OR 1.57, 95% CI 0.55–4.47; n = 181; I2 =0%) was not statistically significant (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 10</a>).<elsevierMultimedia ident="fig0010"></elsevierMultimedia>3.1.9Gastrointestinal (GI) bleedingOverall nine papers reported GI bleeding. Pooling of the data showed no significant differences between using albumin or other therapies (OR 0.98, 95% CI 0.52–1.86; n = 912; I2 =0%). Further analysis comparing albumin with other volume expanders (OR 0.97, 95% CI 0.48–1.99; n = 694; I2 =0%), and SMT (OR 1.01, 95% CI 0.25–4.15; n = 218; I2 =0%) also did not showed significant differences in GI bleeding (<a class="elsevierStyleCrossRef" href="#fig0011">Fig. 11</a>.).<elsevierMultimedia ident="fig0011"></elsevierMultimedia>3.1.10Publication biasFunnel plots were used to evaluate the publication bias across the studied outcomes. Among the studied outcomes, there was no significant publication bias except the MAP outcome. Publication bias was not significant in outcomes like overall mortality outcome suggested by symmetry of plot (<a class="elsevierStyleCrossRef" href="#fig0012">Fig. 12</a>), however significant publication bias was observed for MAP outcome as suggested by the asymmetry of the plot (<a class="elsevierStyleCrossRef" href="#fig0013">Fig. 13</a>).<elsevierMultimedia ident="fig0012"></elsevierMultimedia><elsevierMultimedia ident="fig0013"></elsevierMultimedia>4DiscussionsIn this systematic review and meta-analysis, we have compared albumin to alternative treatment modalities including sodium restriction with diuretics, vasoconstrictors (midodrine and octreotide), and other volume expanders in patients with cirrhotic ascites. The major findings of our study were reduction in paracentesis induced circulatory dysfunction and decrease in hyponatremia with albumin use. Our finding of a reduction in paracentesis induced circulatory dysfunction with albumin by 60% was consistent with the finding of Bernardi et al <a class="elsevierStyleCrossRef" href="#bib0036">[36]</a>. In a subgroup analysis, we found that albumin was superior to other volume expanders in the prevention of PICD. However, no significant difference was observed between albumin and vasoconstrictors. PICD is regarded as the most significant predictor of mortality in patients with tense ascites that are treated by large-volume paracentesis <a class="elsevierStyleCrossRef" href="#bib0025">[25]</a>. Thus, PICD prevention with albumin is a significant finding of our study. Hyponatremia is an important risk factor for hepatic encephalopathy and a predictor of mortality in patients with cirrhosis [<a class="elsevierStyleCrossRef" href="#bib0037">37</a>,<a class="elsevierStyleCrossRef" href="#bib0038">38</a>]. Thus, the benefit of albumin treatment in the reduction of hyponatremia in patients with cirrhosis and ascites can have implications in reducing hospitalization and long-term clinical outcomes. We found no significant benefits with albumin in preventing recurrence of ascites, renal impairment, hepatic encephalopathy, and GI bleeding, although the combination of antibiotics and albumin was found to decrease renal function in the study done by Sort et al <a class="elsevierStyleCrossRef" href="#bib0039">[39]</a>.Human albumin is extracted from donated blood. Thus, there are concerns regarding supply, demand mismatch, and added cost of care with albumin use. Caraceni et al. suggested albumin as a more cost-effective alternative due to the reduction in readmission rate. However, we found no difference in readmission rates between albumin and standard medical treatment groups <a class="elsevierStyleCrossRef" href="#bib0040">[40]</a>.Our meta-analysis is the most comprehensive to date to evaluate the efficacy and safety of albumin in patients with cirrhotic ascites. The inclusion of 21 trials in the analysis adds to the power of the study. We compared albumin treatment to various other modalities separately in our analyses. However, our study has limitations. Most of the included trials are small in size and lack statistical power and carry inherent limitations. There was wide variation in inpatient population, treatment dose, and duration of albumin, and endpoints of various studies. Moreover, studies were conducted over a wide period over three decades. There has been substantial evolution in evidence and practice patterns over the past three decades which could have affected the results pertaining to clinical outcomes.5ConclusionTreatment with albumin in cirrhotic ascites reduced paracentesis-induced circulatory dysfunction and hyponatremia compared to alternative treatment modalities. There was no benefit in mortality, hospital readmission, hepatic encephalopathy, and recurrence of refractory ascites with albumin treatment.DeclarationsEthics approval and consent to participate Not applicableConsent for publication Not applicableAvailability of data and materials the datasets analyzed during the current study are available from the corresponding author on reasonable request.Funding This article did not receive any specific grant from funding agencies in the public, commercial, or any other sectors.Authors' contributions: DBS, PB, YRS, RB and MGK contributed to the concept and design, analysis, and interpretation of data. DBS, PB, SA, JY, and LA contributed to the literature search, data extraction, review and initial manuscript drafting. YRS, RB, BD, MGK, and CAC interpretation of data, revising the manuscript for important intellectual content and approval of the final manuscript.All authors were involved in drafting and revising the manuscript and approved the final version." "textoCompletoSecciones" => array:1 [ "secciones" => array:10 [ 0 => array:3 [ "identificador" => "xres1761527" "titulo" => "Abstract" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abss0001" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec1549120" "titulo" => "Keywords" ] 2 => array:2 [ "identificador" => "xpalclavsec1549121" "titulo" => "Abbreviations" ] 3 => array:2 [ "identificador" => "sec0001" "titulo" => "Introduction" ] 4 => array:3 [ "identificador" => "sec0002" "titulo" => "Methods" "secciones" => array:7 [ 0 => array:2 [ "identificador" => "sec0003" "titulo" => "Types of studies" ] 1 => array:2 [ "identificador" => "sec0004" "titulo" => "Types of participant" ] 2 => array:2 [ "identificador" => "sec0005" "titulo" => "Types of intervention" ] 3 => array:2 [ "identificador" => "sec0006" "titulo" => "Comparator" ] 4 => array:2 [ "identificador" => "sec0007" "titulo" => "Types of outcome measures" ] 5 => array:3 [ "identificador" => "sec0008" "titulo" => "Search methods for identification of studies" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0009" "titulo" => "Electronic searches" ] 1 => array:2 [ "identificador" => "sec0010" "titulo" => "Data collection and analysis" ] 2 => array:2 [ "identificador" => "sec0011" "titulo" => "Selection of studies" ] ] ] 6 => array:3 [ "identificador" => "sec0012" "titulo" => "Data extraction and management" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0013" "titulo" => "Assessment of risk of bias in included studies" ] 1 => array:2 [ "identificador" => "sec0014" "titulo" => "Assessment of heterogeneity" ] 2 => array:2 [ "identificador" => "sec0015" "titulo" => "Data synthesis" ] ] ] ] ] 5 => array:3 [ "identificador" => "sec0016" "titulo" => "Results" "secciones" => array:1 [ 0 => array:3 [ "identificador" => "sec0017" "titulo" => "Quantitative synthesis" "secciones" => array:10 [ 0 => array:2 [ "identificador" => "sec0018" "titulo" => "Paracentesis induced circulatory dysfunction (PICD)" ] 1 => array:2 [ "identificador" => "sec0019" "titulo" => "Mortality outcome" ] 2 => array:2 [ "identificador" => "sec0020" "titulo" => "Re-appearance of ascites" ] 3 => array:2 [ "identificador" => "sec0021" "titulo" => "Hospital readmission" ] 4 => array:2 [ "identificador" => "sec0022" "titulo" => "Mean arterial pressure (MAP) after 4–6 days of therapy" ] 5 => array:2 [ "identificador" => "sec0023" "titulo" => "Hyponatremia" ] 6 => array:2 [ "identificador" => "sec0024" "titulo" => "Renal impairment" ] 7 => array:2 [ "identificador" => "sec0025" "titulo" => "Hepatic encephalopathy (HE)" ] 8 => array:2 [ "identificador" => "sec0026" "titulo" => "Gastrointestinal (GI) bleeding" ] 9 => array:2 [ "identificador" => "sec0027" "titulo" => "Publication bias" ] ] ] ] ] 6 => array:2 [ "identificador" => "sec0028" "titulo" => "Discussions" ] 7 => array:2 [ "identificador" => "sec0029" "titulo" => "Conclusion" ] 8 => array:2 [ "identificador" => "sec0030" "titulo" => "Declarations" ] 9 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2021-04-18" "fechaAceptado" => "2021-06-10" "PalabrasClave" => array:1 [ "en" => array:2 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1549120" "palabras" => array:6 [ 0 => "Ascites" 1 => "Hepatic encephalopathy" 2 => "Liver cirrhosis" 3 => "Paracentesis" 4 => "Serum albumin" 5 => "Human" ] ] 1 => array:4 [ "clase" => "abr" "titulo" => "Abbreviations" "identificador" => "xpalclavsec1549121" "palabras" => array:11 [ 0 => "AASLD" 1 => "EASL" 2 => "GI" 3 => "HE" 4 => "HES" 5 => "HRS" 6 => "MAP" 7 => "Na" 8 => "PAC" 9 => "PICD" 10 => "PRA" ] ] ] ] "tieneResumen" => true "resumen" => array:1 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "Ascites is the most common presentation of decompensated liver cirrhosis. It is treated with therapeutic paracentesis which is associated with several complications. The role of human albumin in patients with cirrhotic ascites remains elusive and has been extensively studied with conflicting results. Thus, in order to fully appraise the available data we sought to perform this systematic review and meta-analysis. Herein we included studies comparing the efficacy and safety of human albumin comparing with other volume expanders and vasoactive agents in patients undergoing paracentesis in cirrhotic ascites. Odds ratio (OR) and mean difference (MD) were used to estimate the outcome with a 95% confidence interval (CI). Albumin use reduced the odds of paracentesis induced circulatory dysfunction (PICD) by 60% (OR 0.40, 95% CI 0.27–0.58). While performing subgroup analysis, albumin use lowered the odds of PICD significantly (OR 0.34, 95% CI 0.22–0.52) in comparison to other colloid volume expanders, but did not lower the odds of PICD in comparison to vasoconstrictor therapy (OR 0.93, 95% CI 0.35–2.45). Albumin was associated with a statistically significant lower incidence of hyponatremia (OR 0.59, 95% CI 0.39–0.88). Albumin did not reduce the overall mortality, readmission rate, recurrence of ascites, mean arterial pressure, incidence of renal impairment, hepatic encephalopathy, and gastrointestinal (GI) bleeding. Thus, treatment with albumin in cirrhotic ascites reduced PICD and hyponatremia although there was no benefit in terms of mortality, readmission rate, recurrence of ascites, hepatic encephalopathy, and GI bleeding." ] ] "NotaPie" => array:10 [ 0 => array:3 [ "etiqueta" => "1" "nota" => "DBS Medical officer, Department of Emergency Medicine, Mangalbare Hospital, Morang, Nepal" "identificador" => "fn1" ] 1 => array:3 [ "etiqueta" => "2" "nota" => "Resident Physician, Department of Internal Medicine, Mount Sinai Hospital, Chicago, IL, USA" "identificador" => "fn2" ] 2 => array:3 [ "etiqueta" => "3" "nota" => "Resident Physician, Department of Internal Medicine, BronxCare Health System, Bronx, NY, USA" "identificador" => "fn3" ] 3 => array:3 [ "etiqueta" => "4" "nota" => "RB Hospitalist, Our Lady of the Lake Hospital, Baton Rouge LA, USA" "identificador" => "fn4" ] 4 => array:3 [ "etiqueta" => "5" "nota" => "SA Intern doctor, Nepalese Army Institute of Health Sciences, Kathmandu, Nepal" "identificador" => "fn5" ] 5 => array:3 [ "etiqueta" => "6" "nota" => "JY Intern doctor, Nepalese Army Institute of Health Sciences, Kathmandu, Nepal" "identificador" => "fn6" ] 6 => array:3 [ "etiqueta" => "7" "nota" => "LA Medical student, Rangpur Medical College, Bangaladesh" "identificador" => "fn7" ] 7 => array:3 [ "etiqueta" => "8" "nota" => "BD Assistant Professor, Department of Internal Medicine, Division of Gastroenterology, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA" "identificador" => "fn8" ] 8 => array:3 [ "etiqueta" => "9" "nota" => "MGK Associate Professor; Department of Internal Medicine; Division of Pulmonary and Critical Care, VCU School of Medicine, Richmond VA; USA" "identificador" => "fn9" ] 9 => array:3 [ "etiqueta" => "10" "nota" => "CAC Assistant Professor, Department of Pulmonary Disease and Critical Care Medicine, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA" "identificador" => "fn10" ] ] "apendice" => array:1 [ 0 => array:1 [ "seccion" => array:1 [ 0 => array:4 [ "apendice" => "<elsevierMultimedia ident="ecom0001"></elsevierMultimedia>" "etiqueta" => "Appendix" "titulo" => "Supplementary materials" "identificador" => "sec0033" ] ] ] ] "multimedia" => array:15 [ 0 => array:8 [ "identificador" => "fig0001" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 4133 "Ancho" => 1709 "Tamanyo" => 809850 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0001" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "ROB 2.0 bias assessment of included studies." ] ] 1 => array:8 [ "identificador" => "fig0002" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 2653 "Ancho" => 2750 "Tamanyo" => 420714 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0002" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "PRISMA Flow Diagram." ] ] 2 => array:8 [ "identificador" => "fig0003" "etiqueta" => "Fig. 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 1979 "Ancho" => 3583 "Tamanyo" => 606239 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0003" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Forest plot showing PICD rate comparing albumin with other therapy using fixed effect model." ] ] 3 => array:8 [ "identificador" => "fig0004" "etiqueta" => "Fig. 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 2843 "Ancho" => 3583 "Tamanyo" => 815800 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0004" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Forest plot showing mortality outcome comparing albumin with other therapy using fixed effect model." ] ] 4 => array:8 [ "identificador" => "fig0005" "etiqueta" => "Fig. 5" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr5.jpeg" "Alto" => 877 "Ancho" => 3583 "Tamanyo" => 303067 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0005" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Forest plot showing re-appearance of ascites comparing albumin with other therapy using fixed effect model." ] ] 5 => array:8 [ "identificador" => "fig0006" "etiqueta" => "Fig. 6" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr6.jpeg" "Alto" => 1836 "Ancho" => 3583 "Tamanyo" => 564164 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0006" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Forest plot showing hospital readmission comparing albumin with other therapy using fixed effect model." ] ] 6 => array:8 [ "identificador" => "fig0007" "etiqueta" => "Fig. 7" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr7.jpeg" "Alto" => 2723 "Ancho" => 3583 "Tamanyo" => 835562 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0007" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Forest plot showing mean difference on MAP comparing albumin with other therapy using a random-effect model." ] ] 7 => array:8 [ "identificador" => "fig0008" "etiqueta" => "Fig. 8" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr8.jpeg" "Alto" => 2991 "Ancho" => 3583 "Tamanyo" => 820795 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0008" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Forest plot showing hyponatremia incidence among albumin and other therapy using fixed effect model." ] ] 8 => array:8 [ "identificador" => "fig0009" "etiqueta" => "Fig. 9" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr9.jpeg" "Alto" => 2621 "Ancho" => 3583 "Tamanyo" => 754907 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0009" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Forest plot showing renal impairment among albumin and other therapy using fixed effect model." ] ] 9 => array:8 [ "identificador" => "fig0010" "etiqueta" => "Fig. 10" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr10.jpeg" "Alto" => 2201 "Ancho" => 3583 "Tamanyo" => 652867 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0010" "detalle" => "Fig. 1" "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Forest plot showing HE among albumin and other therapy using fixed effect model." ] ] 10 => array:8 [ "identificador" => "fig0011" "etiqueta" => "Fig. 11" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr11.jpeg" "Alto" => 2017 "Ancho" => 3583 "Tamanyo" => 613103 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0011" "detalle" => "Fig. 1" "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Forest plot showing GI bleeding among albumin and other therapy using fixed effect model." ] ] 11 => array:8 [ "identificador" => "fig0012" "etiqueta" => "Fig. 12" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr12.jpeg" "Alto" => 1806 "Ancho" => 2583 "Tamanyo" => 185453 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0012" "detalle" => "Fig. 1" "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Funnel plot showing the symmetric distribution of studies suggesting no significant publication bias for mortality outcome." ] ] 12 => array:8 [ "identificador" => "fig0013" "etiqueta" => "Fig. 13" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr13.jpeg" "Alto" => 1783 "Ancho" => 2500 "Tamanyo" => 155791 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0013" "detalle" => "Fig. 1" "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Funnel plot showing the asymmetric distribution of studies suggesting publication bias for MAP outcome." ] ] 13 => array:8 [ "identificador" => "tbl0001" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0014" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "Abbreviations: Alb: Albumin, dl: Deciliter, g: gram, GI: Gastrointestinal, HE: Hepatic Encephalopathy, HES: Hydroxyethyl Starch, hr: Hour, HRS: Hepatorenal Syndrome, IV: Intravenous, L: Liter, MAP: Mean Arterial Pressure, ml: milliliter, N: Sample size, Na: sodium, PAC: Plasma Aldosterone Concentration, Para: Paracentesis, PCD: Paracentesis-induced Circulatory Dysfunction, PRA: Plasma Renin Activity, UOP: urine output." "tablatextoimagen" => array:1 [ 0 => array:1 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><a name="en0001"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black">ID \t\t\t\t\t\t\n \t\t\t\t\t\t</th><a name="en0002"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black">Population \t\t\t\t\t\t\n \t\t\t\t\t\t</th><a name="en0003"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black">Intervention \t\t\t\t\t\t\n \t\t\t\t\t\t</th><a name="en0004"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black">Comparisons \t\t\t\t\t\t\n \t\t\t\t\t\t</th><a name="en0005"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black">Outcome \t\t\t\t\t\t\n \t\t\t\t\t\t</th><a name="en0006"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black">Follow Up Period \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><a name="en0007"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Abootalebi A <a class="elsevierStyleCrossRef" href="#bib0010">[10]</a> et al 2017 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0008"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N = 108 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0009"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Alb, 5 g/L of ascites removed \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0010"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">HES, 5 g/L of ascites removedAlb+ HES, 2.5 g/L Alb 2.5 g/L HES of ascites removed \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0011"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">At day 4, higher MAP in Alb group. No difference in weight, HR, UOP, laboratory values, and LOC. \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0012"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0013"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Abdel-Khalek EE <a class="elsevierStyleCrossRef" href="#bib0019">[19]</a> et al 2010 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0014"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N = 135 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0015"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">20% Alb, 8 g/L of ascites removed \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0016"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">HES 6%, 8 g/L of ascites removed \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0017"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Postparacentesis transient hypotension significantly worse in HES group. At 6th day, no difference in renal or hepatic function, serum electrolytes, or complications. \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0018"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">6-month follow up, no difference in readmissions, complications, or mortality. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0019"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Altman C <a class="elsevierStyleCrossRef" href="#bib0020">[20]</a> et al 1998 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0020"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N = 60 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0021"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Alb, 20 g if less than 2 L of ascites removed; 40 g if 2-5 L of ascites removed \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0022"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">HES group, 32.5 g if less than 2 L of ascites removed; 65 g if 2-5 L of ascites removed \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0023"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Day 1, 3, and 15, no difference in development of renal failure or hyponatremia. \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0024"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Up to 15 days, no difference in complications. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0025"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Appenrodt <a class="elsevierStyleCrossRef" href="#bib0006">[6]</a> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0026"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N = 24 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0027"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Alb, 8 g/L of ascites removed \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0028"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Midodrine, 12.5 mg every 8 h for 2 days, six doses each \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0029"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">On day 6, PICD (>50% increase in pre-treatment renin), 31% (n = 4) Alb, 60% (n = 6) midodrine \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0030"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0031"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Bari K <a class="elsevierStyleCrossRef" href="#bib0021">[21]</a> et al. 2012 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0032"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N =  25 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0033"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Alb, 8 g/L of ascites removed \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0034"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Octreotide long-acting release 20 mg intramuscularly to be repeated every monthMidodrine, 10 mg orally 3 times a day \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0035"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">No significant difference in time to recurrence of ascites.At day 6, no significant difference in PICD, MAP, HR, HRS \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0036"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">10 months, no difference in mortality \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0037"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Fassio E <a class="elsevierStyleCrossRef" href="#bib0022">[22]</a> et al 1992 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0038"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N = 41 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0039"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Alb, 6 g/L of ascites removed \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0040"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Dextran, 6 g/L of ascites removed \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0041"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">At 24 hrs and 96 hrs, no significant difference in renal and liver function tests, MAP, or electrolytes. \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0042"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Approximately 30 weeks, no different in re-admission and mortality. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0043"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Garcia-Compean D et al <a class="elsevierStyleCrossRef" href="#bib0023">[23]</a> 1993 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0044"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N = 35 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0045"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Alb, 5 g/L ascites removed \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0046"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">No albumin \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0047"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">At 12 hr, there was a significant decrease of CO in the no albumin group. At 6 and 24hrs, there was a significantly reduced PRA in the albumin group. At 1 and 6 hrs, there was a significantly reduced PAC in the albumin group. No difference in complications. \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0048"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Frequency of complications after 24 hrs was no different between the groups. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0049"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">García-Compean D <a class="elsevierStyleCrossRef" href="#bib0024">[24]</a> et al 2002 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0050"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N = 96 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0051"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Alb, 8 g/L of ascites removed \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0052"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Dextran-40, 8 g/L of ascites removed \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0053"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">At 24 hour and 48 hrs, there was a significant decrease in MAP in both groups. Significant increase in UOP in both groups at 24 hrs, but only remained significant in the albumin group at 48 hrs. At 48 hrs, PRA was significantly higher in the Dextran-40 group. Significantly more PICD in Dextran-40 group. \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0054"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Up to 44 months, no significant difference in complications, ascites recurrent rates, or mortality. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0055"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Gines P <a class="elsevierStyleCrossRef" href="#bib0002">[2]</a> et al 1988 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0056"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N = 105 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0057"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Alb, 40 g post para, 4-6 L ascites removed daily until resolution of ascites \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0058"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">No Alb, 4-6 L ascites removed daily until resolution of ascites \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0059"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Day 6, no significant difference in standard renal function tests, PRA, and PAC. Paracentesis without albumin was associated with a significant increase in BUN, a marked elevation in PRA and PAC, and a significant reduction in serum sodium concentration. No difference in probability of survival. \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0060"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Up to 40 weeks no significant reappearance of ascites, readmission or death. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0061"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Gines A <a class="elsevierStyleCrossRef" href="#bib0025">[25]</a> et al 1996 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0062"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N = 289 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0063"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Alb, 8 g/L of ascites removed \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0064"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Dextran70, 8 g/L of ascites removedPolygeline, 8 g/L of ascites removed \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0065"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">At day 6, PICD occurred at a significantly greater frequency in the dextran and polygeline groups. Creatinine and PRA increase, and serum sodium decrease was significant in the dextran and polygeline when compared to the alb group. \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0066"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Up to 30 months, no difference in readmission or death. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0067"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Khan MU <a class="elsevierStyleCrossRef" href="#bib0026">[26]</a> et al 2015 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0068"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N = 50 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0069"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Alb, 6 g/L and 125 ml/L fluid of ascites removed \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0070"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Hemaccel 6 g/L and 125 ml/L fluid of ascites removed \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0071"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">At 6 days, no significant difference in creatinine, sodium, or MAP. \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0072"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0073"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Luca A <a class="elsevierStyleCrossRef" href="#bib0027">[27]</a> et al 1995 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0074"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N = 18 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0075"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Alb, 8g/L of ascites removed \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0076"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">No albumin \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0077"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">At 24 h, no significant difference in hemodynamics \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0078"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0079"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Moreau R <a class="elsevierStyleCrossRef" href="#bib0028">[28]</a> et al 2002 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0080"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N = 20 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0081"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Alb, 8 g/L of ascites removed \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0082"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Terlipressin, total dose of 3 mg, administered as 1mg IV at the onset of paracentesis, 8 h and 16 h \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0083"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">At hospital discharge, no significant change in effective arterial blood volume assess by PRC \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0084"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0085"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Moreau R <a class="elsevierStyleCrossRef" href="#bib0029">[29]</a> et al 2006 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0086"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N = 68 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0087"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Alb, variable dosing \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0088"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Synthetic colloid (3.5% polygeline), variable dosing \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0089"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Follow up till 6 months, no significant difference in development of at least one liver-related complication or time-to-first complication.The total number of liver‐related complications adjusted to a 100‐day period was significantly lower in the alb group \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0090"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0091"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Planas R <a class="elsevierStyleCrossRef" href="#bib0030">[30]</a> et al 1990 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0092"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N = 88 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0093"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Alb, 8 g/L of ascites removed \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0094"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Dextran-70 8 g/L of ascites removed \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0095"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">At day 6, no significant difference in renal and hepatic function or serum electrolytes.A significant increase in PRA and PAC was observed in the Dextran group compared to the Alb group. \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0096"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Up to 40 weeks, no significant difference in readmissions or death. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0097"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Salerno F <a class="elsevierStyleCrossRef" href="#bib0031">[31]</a> et al 1987 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0098"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N = 41 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0099"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Albumin with repeated para \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0100"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Diuretics alone \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0101"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Ascites disappeared within 3 or 4 days with paracentesis, but only after 15 days with diuretics. No negative changes were induced in clinical and laboratory parameters of hemodynamic, hepatic and renal function after evacuation of the ascites. \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0102"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Follow-up period for 19.8±2.6 weeks in Alb and 14±2.2 weeks in diuretics.No significant difference in complications or death. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0103"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Salerno F <a class="elsevierStyleCrossRef" href="#bib0032">[33]</a> et al 1991 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0104"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N = 54 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0105"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Alb, 20% 30mL/L of ascites removed \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0106"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Hemaccel 3.5%, 150mL/L of ascites removed \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0107"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">At day 1, 3, and 6, hemodynamics, electrolytes, and hormone levels were not significantly different between the groups expect for albumin concentration; significantly higher in the Alb group at day 1, 3, and 6).No significant difference in complications. \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0108"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Up to 172 weeks, probability of recurrence of massive ascites and probability of survival was similar between the two groups. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0109"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Singh V <a class="elsevierStyleCrossRef" href="#bib0033">[33]</a> et al 2008 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0110"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N = 40 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0111"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Alb \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0112"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Midodrine \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0113"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Plasma renin activity at 6 days after paracentesis did not differ in the two groups. Significant increase in 24-h urine volume and urine sodium excretion in the midodrine group. Midodrine therapy was cheaper than albumin therapy. \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0114"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">No difference in repeat para within 3 months of treatment. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0115"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Singh V <a class="elsevierStyleCrossRef" href="#bib0034">[34]</a> et al 2006 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0116"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N = 40 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0117"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Alb, 8g/L of ascites removed \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0118"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Terlipressin, total dose of 3mg, administered as 1mg IV at the onset of paracentesis, 8 h and 16 h \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0119"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">No significant difference in development of PICD, renal impairment or hyponatremia at day 4–6 post intervention. \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0120"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">No difference in repeat para within 3 months of treatment. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0121"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Sola-Vera J <a class="elsevierStyleCrossRef" href="#bib0035">[35]</a> et al 2003 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0122"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N = 72 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0123"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Alb, 8 g/L of ascites removed \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0124"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">IV saline infusion, constant rate via a pump infusion device (170 mL of 3.5% saline solution / L of ascites removed at 999 mL/h) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0125"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">The incidence of PICD was significantly higher in the saline group versus the albumin group, however not significant if less than 6L of ascitic fluid was removed. \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0126"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">No significant differences betweenclinical and laboratory data before second paracentesis between the two groups. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0127"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Yosry <a class="elsevierStyleCrossRef" href="#bib0011">[11]</a> A et al 2018 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0128"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N = 75 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0129"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Alb, 8 g/L of ascites removed \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0130"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">2-day midodrine, 12.5mg q8hrs for 2 days30-day midodrine, 12.5mg q8hrs for 30 days \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0131"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Significant increase in 24 h urine Na excretion and renal perfusion at 30 days in the 30-day midodrine group. Both midodrine groups were significantly lower in cost than Alb. No significant difference in development of renal impairment, hyponatremia, or mortality at day 6 and 30. \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0132"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">up to day 30 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] ] ] ] "descripcion" => array:1 [ "en" => "Qualitative summary of included studies." ] ] 14 => array:6 [ "identificador" => "ecom0001" "tipo" => "MULTIMEDIAECOMPONENTE" "mostrarFloat" => false "mostrarDisplay" => true "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0015" "detalle" => "Image, application " "rol" => "short" ] ] "Ecomponente" => array:2 [ "fichero" => "mmc1.docx" "ficheroTamanyo" => 170724 ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "cebibsec1" "bibliografiaReferencia" => array:40 [ 0 => array:3 [ "identificador" => "bib0001" "etiqueta" => "[1]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "G D'Amico" 1 => "G Garcia-Tsao" 2 => "L. Pagliaro" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jhep.2005.10.013" "Revista" => array:6 [ "tituloSerie" => "J Hepatol" "fecha" => "2006" "volumen" => "44" "paginaInicial" => "217" "paginaFinal" => "231" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16298014" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0002" "etiqueta" => "[2]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P Ginès" 1 => "L Titó" 2 => "V Arroyo" 3 => "R Planas" 4 => "J Panés" 5 => "J Viver" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/0016-5085(88)90691-9" "Revista" => array:6 [ "tituloSerie" => "Gastroenterology" "fecha" => "1988" "volumen" => "94" "paginaInicial" => "1493" "paginaFinal" => "1502" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/3360270" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0003" "etiqueta" => "[3]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Spontaneous bacterial peritonitis in cirrhotic patients: is prophylactic propranolol therapy beneficial?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "E Cholongitas" 1 => "G.V. Papatheodoridis" 2 => "EK Manesis" 3 => "AK Burroughs" 4 => "AJ. Archimandritis" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1440-1746.2005.03982.x" "Revista" => array:6 [ "tituloSerie" => "J Gastroenterol Hepatol" "fecha" => "2006" "volumen" => "21" "paginaInicial" => "581" "paginaFinal" => "587" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16638103" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0004" "etiqueta" => "[4]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Guidelines on the management of ascites in cirrhosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "KP Moore" 1 => "GP. Aithal" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/gut.2006.099580" "Revista" => array:3 [ "tituloSerie" => "Gut" "fecha" => "2006" "volumen" => "55" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0005" "etiqueta" => "[5]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hemodynamic changes in patients developing effective hypovolemia after total paracentesis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "MC Vila" 1 => "R Solà" 2 => "L Molina" 3 => "M Andreu" 4 => "S Coll" 5 => "J Gana" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0168-8278(98)80288-2" "Revista" => array:6 [ "tituloSerie" => "J Hepatol" "fecha" => "1998" "volumen" => "28" "paginaInicial" => "639" "paginaFinal" => "645" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9566833" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0006" "etiqueta" => "[6]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "B Appenrodt" 1 => "A Wolf" 2 => "F Grünhage" 3 => "J Trebicka" 4 => "M Schepke" 5 => "C Rabe" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1478-3231.2008.01734.x" "Revista" => array:6 [ "tituloSerie" => "Liver Int" "fecha" => "2008" "volumen" => "28" "paginaInicial" => "1019" "paginaFinal" => "1025" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18410283" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0007" "etiqueta" => "[7]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M Pericleous" 1 => "A Sarnowski" 2 => "A Moore" 3 => "R Fijten" 4 => "M. Zaman" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/MEG.0000000000000548" "Revista" => array:6 [ "tituloSerie" => "Eur J Gastroenterol Hepatol" "fecha" => "2016" "volumen" => "28" "paginaInicial" => "e10" "paginaFinal" => "e18" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26671516" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0008" "etiqueta" => "[8]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "BA. Runyon" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/hep.26359" "Revista" => array:6 [ "tituloSerie" => "Hepatology" "fecha" => "2013" "volumen" => "57" "paginaInicial" => "1651" "paginaFinal" => "1653" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23463403" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0009" "etiqueta" => "[9]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Insufficient evidence of benefit regarding mortality due to albumin substitution in HCC-free cirrhotic patients undergoing large volume paracentesis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F Kütting" 1 => "J Schubert" 2 => "J Franklin" 3 => "A Bowe" 4 => "V Hoffmann" 5 => "M Demir" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/jgh.13421" "Revista" => array:6 [ "tituloSerie" => "J Gastroenterol Hepatol" "fecha" => "2017" "volumen" => "32" "paginaInicial" => "327" "paginaFinal" => "338" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27149296" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0010" "etiqueta" => "[10]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparing the effects of hydroxyethyl starch and albumin in cirrhotic patients with tense ascites; a randomized clinical trial" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "A Abootalebi" 1 => "S Khazaei" 2 => "M Minakari" 3 => "M Nasr-Isfahani" 4 => "M Esmailian" 5 => "F. Heydari" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.22114/AJEM.v1i1.17" "Revista" => array:3 [ "tituloSerie" => "Adv J Emerg Med" "fecha" => "2017" "volumen" => "1" ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0011" "etiqueta" => "[11]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Oral midodrine is comparable to albumin infusion in cirrhotic patients with refractory ascites undergoing large-volume paracentesis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "A Yosry" 1 => "ZA Soliman" 2 => "R Eletreby" 3 => "I Hamza" 4 => "A Ismail" 5 => "MA. Elkady" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/MEG.0000000000001277" "Revista" => array:6 [ "tituloSerie" => "Eur J Gastroenterol Hepatol" "fecha" => "2019" "volumen" => "31" "paginaInicial" => "345" "paginaFinal" => "351" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30312183" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0012" "etiqueta" => "[12]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A Liberati" 1 => "DG Altman" 2 => "J Tetzlaff" 3 => "C Mulrow" 4 => "PC Gøtzsche" 5 => "JPA Ioannidis" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/bmj.b2700" "Revista" => array:4 [ "tituloSerie" => "BMJ" "fecha" => "2009" "volumen" => "339" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19574308" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0013" "etiqueta" => "[13]" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Shrestha D, Budhathoki P, Sedhai YR, Awal S, Yadav J, Awal L, et al. A meta-analysis of efficacy and safety of human serum albumin treatment in patients with ascites due to cirrhosis. PROSPERO 2020 CRD42020223464 n.d. <a target="_blank" href="https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=223464">https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=223464</a> (accessed May 27, 2021 )." ] ] ] 13 => array:3 [ "identificador" => "bib0014" "etiqueta" => "[14]" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "How can I cite Covidence? n.d. <a target="_blank" href="https://support.covidence.org/help/how-can-i-cite-covidence">https://support.covidence.org/help/how-can-i-cite-covidence</a> (accessed January 26, 2021 )." ] ] ] 14 => array:3 [ "identificador" => "bib0015" "etiqueta" => "[15]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "RoB 2: a revised tool for assessing risk of bias in randomised trials" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "JAC Sterne" 1 => "J Savović" 2 => "MJ Page" 3 => "RG Elbers" 4 => "NS Blencowe" 5 => "I Boutron" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/bmj.l4898" "Revista" => array:4 [ "tituloSerie" => "BMJ" "fecha" => "2019" "volumen" => "366" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31462531" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0016" "etiqueta" => "[16]" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "9.5.2 Identifying and measuring heterogeneity n.d. <a target="_blank" href="https://handbook-5-1.cochrane.org/chapter_9/9_5_2_identifying_and_measuring_heterogeneity.htm">https://handbook-5-1.cochrane.org/chapter_9/9_5_2_identifying_and_measuring_heterogeneity.htm</a> (accessed December 18, 2020)." ] ] ] 16 => array:3 [ "identificador" => "bib0017" "etiqueta" => "[17]" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "RevMan for non-Cochrane reviews | Cochrane Training n.d. <a target="_blank" href="https://training.cochrane.org/online-learning/core-software-cochrane-reviews/revman/revman-non-cochrane-reviews">https://training.cochrane.org/online-learning/core-software-cochrane-reviews/revman/revman-non-cochrane-reviews</a> (accessed January 26, 2021)." ] ] ] 17 => array:3 [ "identificador" => "bib0018" "etiqueta" => "[18]" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Mean Variance Estimation n.d. <a target="_blank" href="https://web.archive.org/web/20181224162602/http:/www.comp.hkbu.edu.hk/~xwan/median2mean.html">https://web.archive.org/web/20181224162602/http:/www.comp.hkbu.edu.hk/∼xwan/median2mean.html</a> (accessed December 19, 2020)." ] ] ] 18 => array:3 [ "identificador" => "bib0019" "etiqueta" => "[19]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Randomized trial comparing human albumin and hydroxyethyl starch 6% as plasma expanders for treatment of patients with liver cirrhosis and tense ascites following large volume paracentesis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "EE Abdel-Khalek" 1 => "SE. Arif" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ajg.2010.01.006" "Revista" => array:5 [ "tituloSerie" => "Arab J Gastroenterol" "fecha" => "2010" "volumen" => "11" "paginaInicial" => "24" "paginaFinal" => "29" ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0020" "etiqueta" => "[20]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "C Altman" 1 => "B Bernard" 2 => "D Roulot" 3 => "RL Vitte" 4 => "O. Ink" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/00042737-199801000-00002" "Revista" => array:6 [ "tituloSerie" => "Eur J Gastroenterol Hepatol" "fecha" => "1998" "volumen" => "10" "paginaInicial" => "5" "paginaFinal" => "10" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9512946" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0021" "etiqueta" => "[21]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The combination of octreotide and midodrine is not superior to albumin in preventing recurrence of ascites after large-volume paracentesis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K Bari" 1 => "C Miñano" 2 => "M Shea" 3 => "IB Inayat" 4 => "HJ Hashem" 5 => "HC Gilles" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.cgh.2012.06.027" "Revista" => array:6 [ "tituloSerie" => "Clin Gastroenterol Hepatol" "fecha" => "2012" "volumen" => "10" "paginaInicial" => "1169" "paginaFinal" => "1175" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22801062" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0022" "etiqueta" => "[22]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Paracentesis with Dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites. Results of a randomized study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E Fassio" 1 => "R Terg" 2 => "G Landeira" 3 => "R Abecasis" 4 => "M Salemne" 5 => "A Podesta" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/0168-8278(92)90176-P" "Revista" => array:6 [ "tituloSerie" => "J Hepatol" "fecha" => "1992" "volumen" => "14" "paginaInicial" => "310" "paginaFinal" => "316" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1380024" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0023" "etiqueta" => "[23]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Total therapeutic paracentesis (TTP) with and without intravenous albumin in the treatment of cirrhotic tense ascites: a randomized controlled trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D Garcia-Compeán" 1 => "JZ Villarreal" 2 => "HB Cuevas" 3 => "DAG Cantü" 4 => "M Estrella" 5 => "EG Tamez" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1600-0676.1993.tb00637.x" "Revista" => array:6 [ "tituloSerie" => "Liver" "fecha" => "1993" "volumen" => "13" "paginaInicial" => "233" "paginaFinal" => "238" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8259034" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0024" "etiqueta" => "[24]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D García-Compean" 1 => "P Blanc" 2 => "D Larrey" 3 => "J-P Daures" 4 => "J Hirtz" 5 => "E Mendoza" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Ann Hepatol" "fecha" => "2002" "volumen" => "1" "paginaInicial" => "29" "paginaFinal" => "35" ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0025" "etiqueta" => "[25]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A Gines" 1 => "G Fernandez-Esparrach" 2 => "A Monescillo" 3 => "C Vila" 4 => "E Domenech" 5 => "R Abecasis" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0016-5085(96)70068-9" "Revista" => array:6 [ "tituloSerie" => "Gastroenterology" "fecha" => "1996" "volumen" => "111" "paginaInicial" => "1002" "paginaFinal" => "1010" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8831595" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0026" "etiqueta" => "[26]" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Rahim UR, Latif M. Hemaccel as a Cheaper Alternative to Human Albumin for Plasma Expansion during Paracentesis in Cirrhotic patients. n.d." ] ] ] 26 => array:3 [ "identificador" => "bib0027" "etiqueta" => "[27]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A Luca" 1 => "JC García-Pagán" 2 => "J Bosch" 3 => "F Feu" 4 => "W Jiménez" 5 => "A Ginés" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Hepatology" "fecha" => "1995" "volumen" => "22" "paginaInicial" => "753" "paginaFinal" => "758" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7657279" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0028" "etiqueta" => "[28]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R Moreau" 1 => "D Valla" 2 => "D Lebrec" 3 => "T Asselah" 4 => "B Condat" 5 => "C De Kerguenec" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/gut.50.1.90" "Revista" => array:6 [ "tituloSerie" => "Gut" "fecha" => "2002" "volumen" => "50" "paginaInicial" => "90" "paginaFinal" => "94" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11772973" "web" => "Medline" ] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0029" "etiqueta" => "[29]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R Moreau" 1 => "DC Valla" 2 => "I Durand-Zaleski" 3 => "JP Bronowicki" 4 => "F Durand" 5 => "JC Chaput" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1478-3231.2005.01188.x" "Revista" => array:6 [ "tituloSerie" => "Liver Int" "fecha" => "2006" "volumen" => "26" "paginaInicial" => "46" "paginaFinal" => "54" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16420509" "web" => "Medline" ] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0030" "etiqueta" => "[30]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R Planas" 1 => "P Ginès" 2 => "V Arroyo" 3 => "J Llach" 4 => "J Panés" 5 => "V Vargas" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/0016-5085(90)90481-F" "Revista" => array:6 [ "tituloSerie" => "Gastroenterology" "fecha" => "1990" "volumen" => "99" "paginaInicial" => "1736" "paginaFinal" => "1744" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1699835" "web" => "Medline" ] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0031" "etiqueta" => "[31]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Repeated paracentesis and i.v. albumin infusion to treat “tense” ascites in cirrhotic patients. A safe alternative therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F Salerno" 1 => "S Badalamenti" 2 => "P Incerti" 3 => "S Tempini" 4 => "B Restelli" 5 => "S Bruno" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0168-8278(87)80067-3" "Revista" => array:6 [ "tituloSerie" => "J Hepatol" "fecha" => "1987" "volumen" => "5" "paginaInicial" => "102" "paginaFinal" => "108" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/3655306" "web" => "Medline" ] ] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0032" "etiqueta" => "[32]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Randomized comparative study of hemaccel vs. albumin infusion after total paracentesis in cirrhotic patients with refractory ascites" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "F Salerno" 1 => "S Badalamenti" 2 => "E Lorenzano" 3 => "P Moser" 4 => "P. Incerti" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Hepatology" "fecha" => "1991" "volumen" => "13" "paginaInicial" => "707" "paginaFinal" => "713" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1826281" "web" => "Medline" ] ] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0033" "etiqueta" => "[33]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: a randomized pilot study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "V Singh" 1 => "PC Dheerendra" 2 => "B Singh" 3 => "CK Nain" 4 => "D Chawla" 5 => "N Sharma" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1572-0241.2008.01787.x" "Revista" => array:6 [ "tituloSerie" => "Am J Gastroenterol" "fecha" => "2008" "volumen" => "103" "paginaInicial" => "1399" "paginaFinal" => "1405" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18547224" "web" => "Medline" ] ] ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0034" "etiqueta" => "[34]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "V Singh" 1 => "R Kumar" 2 => "CK Nain" 3 => "B Singh" 4 => "AK. Sharma" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1440-1746.2006.04182.x" "Revista" => array:6 [ "tituloSerie" => "J Gastroenterol Hepatol" "fecha" => "2006" "volumen" => "21" "paginaInicial" => "303" "paginaFinal" => "307" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16460491" "web" => "Medline" ] ] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0035" "etiqueta" => "[35]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J Sola-Vera" 1 => "J Miñana" 2 => "E Ricart" 3 => "M Planella" 4 => "B González" 5 => "X Torras" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/jhep.2003.50169" "Revista" => array:6 [ "tituloSerie" => "Hepatology" "fecha" => "2003" "volumen" => "37" "paginaInicial" => "1147" "paginaFinal" => "1153" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12717396" "web" => "Medline" ] ] ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0036" "etiqueta" => "[36]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "M Bernardi" 1 => "P Caraceni" 2 => "RJ Navickis" 3 => "MM. Wilkes" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/hep.24786" "Revista" => array:6 [ "tituloSerie" => "Hepatology" "fecha" => "2012" "volumen" => "55" "paginaInicial" => "1172" "paginaFinal" => "1181" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22095893" "web" => "Medline" ] ] ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib0037" "etiqueta" => "[37]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hyponatremia and mortality among patients on the liver-transplant waiting list" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "WR Kim" 1 => "SW Biggins" 2 => "WK Kremers" 3 => "RH Wiesner" 4 => "PS Kamath" 5 => "JT Benson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/nejmoa0801209" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2008" "volumen" => "359" "paginaInicial" => "1018" "paginaFinal" => "1026" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18768945" "web" => "Medline" ] ] ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib0038" "etiqueta" => "[38]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M Guevara" 1 => "ME Baccaro" 2 => "J Ríos" 3 => "M Martín-Llahí" 4 => "J Uriz" 5 => "LR del Arbol" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1478-3231.2010.02293.x" "Revista" => array:6 [ "tituloSerie" => "Liver Int" "fecha" => "2010" "volumen" => "30" "paginaInicial" => "1137" "paginaFinal" => "1142" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20602681" "web" => "Medline" ] ] ] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib0039" "etiqueta" => "[39]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P Sort" 1 => "M Navasa" 2 => "V Arroyo" 3 => "X Aldeguer" 4 => "R Planas" 5 => "L Ruiz-del-Arbol" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/nejm199908053410603" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "1999" "volumen" => "341" "paginaInicial" => "403" "paginaFinal" => "409" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10432325" "web" => "Medline" ] ] ] ] ] ] ] ] 39 => array:3 [ "identificador" => "bib0040" "etiqueta" => "[40]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P Caraceni" 1 => "O Riggio" 2 => "P Angeli" 3 => "C Alessandria" 4 => "S Neri" 5 => "FG Foschi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(18)30840-7" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2018" "volumen" => "391" "paginaInicial" => "2417" "paginaFinal" => "2429" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29861076" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/16652681/000000260000000C/v5_202208200714/S1665268121002465/v5_202208200714/en/main.assets" "Apartado" => array:4 [ "identificador" => "77774" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Concise reviews" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/16652681/000000260000000C/v5_202208200714/S1665268121002465/v5_202208200714/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268121002465?idApp=UINPBA00004N"]

Statistics

Concise review

Dhan Bahadur Shresthaa,1, Pravash Budhathokib,2, Yub Raj Sedhaic,3,

Corresponding author

YubRaj.Sedhai@vcuhealth.org

Corresponding author.

, Ramkaji Baniyad,4, Shila Awale,5, Jashpal Yadave,6, Lila Awalf,7, Brian Davisg,8, Markos G. Kashiourish,9, Casey A. Cableh,10

a Department of Internal Medicine, Mount Sinai Hospital, Chicago, IL, USA

b Department of Internal Medicine, BronxCare Health System, Bronx, NY, USA

c Department of Internal Medicine, Division of Hospital Medicine, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA

d Department of Internal Medicine, Our Lady of the Lake Regional Medical Center; Baton Rouge, LA, USA

e Nepalese Army Institute of Health Sciences, Kathmandu, Nepal

f Rangpur Medical College, Rangpur, Bangladesh

g Department of Internal Medicine, Division of Gastroenterology, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA

h Department of Pulmonary Disease and Critical Care Medicine, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA

Read

3141

Times
was read the article

660

Total PDF

2481

Total HTML

Share statistics

 array:24 [
  "pii" => "S1665268121002465"
  "issn" => "16652681"
  "doi" => "10.1016/j.aohep.2021.100547"
  "estado" => "S300"
  "fechaPublicacion" => "2021-12-01"
  "aid" => "100547"
  "copyright" => "Fundaci&#243;n Cl&#237;nica M&#233;dica Sur&#44; A&#46;C&#46;"
  "copyrightAnyo" => "2021"
  "documento" => "article"
  "crossmark" => 1
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "rev"
  "cita" => "Ann Hepatol. 2021;26C:"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:1 [
    "total" => 0
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S1665268121002337"
    "issn" => "16652681"
    "doi" => "10.1016/j.aohep.2021.100534"
    "estado" => "S300"
    "fechaPublicacion" => "2021-12-01"
    "aid" => "100534"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "rev"
    "cita" => "Ann Hepatol. 2021;26C:"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Concise review</span>"
      "titulo" => "Alternative splicing and liver disease"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => "en"
      "contieneResumen" => array:1 [
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig0003"
          "etiqueta" => "Fig&#46; 3&#46;"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr3.jpeg"
              "Alto" => 1266
              "Ancho" => 2925
              "Tamanyo" => 170461
            ]
          ]
          "detalles" => array:1 [
            0 => array:3 [
              "identificador" => "alt0003"
              "detalle" => "Fig&#46; "
              "rol" => "short"
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spara003" class="elsevierStyleSimplePara elsevierViewall">Diagram exemplifying how alteration of SRSF3 can result in liver pathologies&#46; &#40;A&#41; hepatic fibrosis&#47; liver inflammation reduces the expression levels of SRSF3 via neddylation&#46; Decreased SRSF3 expression in the nucleus &#40;blue circle with dotted circumference&#41; affects the inclusion or exclusion of hundreds of exons&#44; a few<span class="elsevierStyleCrossOut">&#44;</span> of which are known to be central to NAFLD&#44; NASH&#44; and liver cirrhosis liver are indicated&#46; &#40;B&#41; Hepatocyte growth factor&#44; binding to hepatocyte growth factor receptor &#40;C-Met&#41;&#44; induces the PI3K&#47;Akt signaling pathway to decrease SRSF3 levels&#46; The decrease in SRSF3 levels results in an alternative splicing event within the SRSF1 gene producing an isoform that undergoes nonsense-mediated decay&#46; This results in a decreased in SRSF1 expression&#46; Low expression of SRSF1 in the nucleus produces a variety of alterations in the splicing events among which that of the tumor suppressor Kruppel-like factor 6 &#40;KLF6&#41;&#44; enhancing the splicing pattern SV1 isoform <a class="elsevierStyleCrossRef" href="#bib0066">&#91;66&#93;</a>&#44; which leads to increased cell proliferation as it antagonizes the ability of wild-type KLF6 to suppress it&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Marco Baralle, Francisco&#46; E&#46; Baralle"
          "autores" => array:2 [
            0 => array:2 [
              "nombre" => "Marco"
              "apellidos" => "Baralle"
            ]
            1 => array:2 [
              "nombre" => "Francisco&#46; E&#46;"
              "apellidos" => "Baralle"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268121002337?idApp=UINPBA00004N"
    "url" => "/16652681/000000260000000C/v5_202208200714/S1665268121002337/v5_202208200714/en/main.assets"
  ]
  "itemAnterior" => array:18 [
    "pii" => "S1665268121002568"
    "issn" => "16652681"
    "doi" => "10.1016/j.aohep.2021.100557"
    "estado" => "S300"
    "fechaPublicacion" => "2021-12-01"
    "aid" => "100557"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "rev"
    "cita" => "Ann Hepatol. 2021;26C:"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Concise reviews</span>"
      "titulo" => "Pregnancy in Chronic Liver Disease&#58; Before and After Transplantation"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => "en"
      "contieneResumen" => array:1 [
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Amr Dokmak, Hirsh D&#46; Trivedi, Alan Bonder, Jacqueline Wolf"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Amr"
              "apellidos" => "Dokmak"
            ]
            1 => array:2 [
              "nombre" => "Hirsh D&#46;"
              "apellidos" => "Trivedi"
            ]
            2 => array:2 [
              "nombre" => "Alan"
              "apellidos" => "Bonder"
            ]
            3 => array:2 [
              "nombre" => "Jacqueline"
              "apellidos" => "Wolf"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268121002568?idApp=UINPBA00004N"
    "url" => "/16652681/000000260000000C/v5_202208200714/S1665268121002568/v5_202208200714/en/main.assets"
  ]
  "en" => array:19 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Concise review</span>"
    "titulo" => "Safety and efficacy of human serum albumin treatment in patients with cirrhotic ascites undergoing paracentesis&#58; A systematic review and meta-analysis"
    "tieneTextoCompleto" => true
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Dhan Bahadur Shrestha, Pravash Budhathoki, Yub Raj Sedhai, Ramkaji Baniya, Shila Awal, Jashpal Yadav, Lila Awal, Brian Davis, Markos G&#46; Kashiouris, Casey A&#46; Cable"
        "autores" => array:10 [
          0 => array:4 [
            "nombre" => "Dhan Bahadur"
            "apellidos" => "Shrestha"
            "email" => array:1 [
              0 => "medhan75@gmail.com"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0001"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">1</span>"
                "identificador" => "fn1"
              ]
            ]
          ]
          1 => array:4 [
            "nombre" => "Pravash"
            "apellidos" => "Budhathoki"
            "email" => array:1 [
              0 => "pravash.budhathoki123@gmail.com"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0002"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">2</span>"
                "identificador" => "fn2"
              ]
            ]
          ]
          2 => array:4 [
            "nombre" => "Yub Raj"
            "apellidos" => "Sedhai"
            "email" => array:1 [
              0 => "YubRaj.Sedhai@vcuhealth.org"
            ]
            "referencia" => array:3 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0003"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">3</span>"
                "identificador" => "fn3"
              ]
              2 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0001"
              ]
            ]
          ]
          3 => array:4 [
            "nombre" => "Ramkaji"
            "apellidos" => "Baniya"
            "email" => array:1 [
              0 => "rbaniya.md@gmail.com"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "aff0004"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">4</span>"
                "identificador" => "fn4"
              ]
            ]
          ]
          4 => array:4 [
            "nombre" => "Shila"
            "apellidos" => "Awal"
            "email" => array:1 [
              0 => "shila.awal@naihs.edu.np"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">e</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">5</span>"
                "identificador" => "fn5"
              ]
            ]
          ]
          5 => array:4 [
            "nombre" => "Jashpal"
            "apellidos" => "Yadav"
            "email" => array:1 [
              0 => "jashpal.yadav@naihs.edu.np"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">e</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">6</span>"
                "identificador" => "fn6"
              ]
            ]
          ]
          6 => array:4 [
            "nombre" => "Lila"
            "apellidos" => "Awal"
            "email" => array:1 [
              0 => "lilaawal1998@gmail.com"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">f</span>"
                "identificador" => "aff0006"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">7</span>"
                "identificador" => "fn7"
              ]
            ]
          ]
          7 => array:4 [
            "nombre" => "Brian"
            "apellidos" => "Davis"
            "email" => array:1 [
              0 => "Brian.Davis1@vcuhealth.org"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">g</span>"
                "identificador" => "aff0007"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">8</span>"
                "identificador" => "fn8"
              ]
            ]
          ]
          8 => array:4 [
            "nombre" => "Markos G&#46;"
            "apellidos" => "Kashiouris"
            "email" => array:1 [
              0 => "Markos.Kashiouris@vcuhealth.org"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">h</span>"
                "identificador" => "aff0008"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">9</span>"
                "identificador" => "fn9"
              ]
            ]
          ]
          9 => array:4 [
            "nombre" => "Casey A&#46;"
            "apellidos" => "Cable"
            "email" => array:1 [
              0 => "Casey.Cable@vcuhealth.org"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">h</span>"
                "identificador" => "aff0008"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">10</span>"
                "identificador" => "fn10"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:8 [
          0 => array:3 [
            "entidad" => "Department of Internal Medicine&#44; Mount Sinai Hospital&#44; Chicago&#44; IL&#44; USA"
            "etiqueta" => "a"
            "identificador" => "aff0001"
          ]
          1 => array:3 [
            "entidad" => "Department of Internal Medicine&#44; BronxCare Health System&#44; Bronx&#44; NY&#44; USA"
            "etiqueta" => "b"
            "identificador" => "aff0002"
          ]
          2 => array:3 [
            "entidad" => "Department of Internal Medicine&#44; Division of Hospital Medicine&#44; Virginia Commonwealth University&#44; School of Medicine&#44; Richmond&#44; VA&#44; USA"
            "etiqueta" => "c"
            "identificador" => "aff0003"
          ]
          3 => array:3 [
            "entidad" => "Department of Internal Medicine&#44; Our Lady of the Lake Regional Medical Center&#59; Baton Rouge&#44; LA&#44; USA"
            "etiqueta" => "d"
            "identificador" => "aff0004"
          ]
          4 => array:3 [
            "entidad" => "Nepalese Army Institute of Health Sciences&#44; Kathmandu&#44; Nepal"
            "etiqueta" => "e"
            "identificador" => "aff0005"
          ]
          5 => array:3 [
            "entidad" => "Rangpur Medical College&#44; Rangpur&#44; Bangladesh"
            "etiqueta" => "f"
            "identificador" => "aff0006"
          ]
          6 => array:3 [
            "entidad" => "Department of Internal Medicine&#44; Division of Gastroenterology&#44; Virginia Commonwealth University&#44; School of Medicine&#44; Richmond&#44; VA&#44; USA"
            "etiqueta" => "g"
            "identificador" => "aff0007"
          ]
          7 => array:3 [
            "entidad" => "Department of Pulmonary Disease and Critical Care Medicine&#44; Virginia Commonwealth University&#44; School of Medicine&#44; Richmond&#44; VA&#44; USA"
            "etiqueta" => "h"
            "identificador" => "aff0008"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0001"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:8 [
        "identificador" => "fig0006"
        "etiqueta" => "Fig&#46; 6"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr6.jpeg"
            "Alto" => 1836
            "Ancho" => 3583
            "Tamanyo" => 564164
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "alt0006"
            "detalle" => "Fig&#46; "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spara006" class="elsevierStyleSimplePara elsevierViewall">Forest plot showing hospital readmission comparing albumin with other therapy using fixed effect model&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0001" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">1</span><span class="elsevierStyleSectionTitle" id="cesectitle0004">Introduction</span><p id="para0011" class="elsevierStylePara elsevierViewall">Ascites is the most common presentation of decompensated cirrhosis and is associated with complications like spontaneous bacterial peritonitis and 50&#37; mortality at 2 years <a class="elsevierStyleCrossRef" href="#bib0001">&#91;1&#93;</a>&#46; It produces symptoms including abdominal distension&#44; abdominal discomfort&#44; dyspnea&#44; and spontaneous bacterial peritonitis often necessitating hospitalization &#91;<a class="elsevierStyleCrossRef" href="#bib0002">2</a>&#44;<a class="elsevierStyleCrossRef" href="#bib0003">3</a>&#93;&#46; Therapeutic paracentesis is the first line of treatment for patients with tense &#40;i&#46;e&#46;&#44; grade 3&#41; and refractory ascites <a class="elsevierStyleCrossRef" href="#bib0004">&#91;4&#93;</a>&#46; Patients with liver disease have altered circulatory physiology&#44; with splanchnic arteriolar vasodilation&#44; hyperdynamic circulation&#44; and decreased effective arterial blood volume&#46; It is also associated with activation of the renin-angiotensin-aldosterone system &#40;RAAS&#41; and sympathetic nervous system &#40;SNS&#41;&#44; along with an increased antidiuretic hormone levels and sodium and water retention&#46; Paracentesis substantially influences hemodynamics in an already altered physiological state <a class="elsevierStyleCrossRef" href="#bib0005">&#91;5&#93;</a>&#46; Therapeutic paracentesis especially large-volume paracentesis &#40;LVP&#41; is associated with paracentesis-induced circulatory dysfunction &#40;PICD&#41; which is defined as a 50&#37; increase in plasma renin activity &#40;PRA&#41; over the baseline on the sixth day after treatment&#44; up to a value &#62; 4&#8201;ng&#47;mL per hour <a class="elsevierStyleCrossRef" href="#bib0006">&#91;6&#93;</a>&#46;</p><p id="para0012" class="elsevierStylePara elsevierViewall">The role of adjunctive albumin infusion in preventing PICD after LVP has been studied since the 1980s <a class="elsevierStyleCrossRef" href="#bib0002">&#91;2&#93;</a>&#46; Guidelines dealing with the management of ascites vary in their recommendations&#46; The current European Association for the Study of the Liver &#40;EASL&#41; guideline &#40;2016&#41; recommends the infusion of human albumin after paracentesis&#44; regardless of volume&#44; although emphasizing the need for its substitution after a drained volume of 5&#8201;L or more&#46; While the American Association for the Study of Liver Diseases &#40;AASLD&#41; guideline &#40;2013&#41; recommends albumin infusion after a paracentesis of 5 L or more&#44; however&#44; may not be necessary for a single paracentesis of less than 4&#8211;5L &#91;<a class="elsevierStyleCrossRef" href="#bib0007">7</a>&#44;<a class="elsevierStyleCrossRef" href="#bib0008">8</a>&#93;&#46;</p><p id="para0013" class="elsevierStylePara elsevierViewall">It is worthwhile to note the limited availability and a worldwide shortage of albumin&#46; Albumin is extracted from human serum&#44; although having fewer side effects&#44; does carry a theoretical risk of transmission of diseases&#46; Although the cost varies globally&#44; considering the amount of albumin required after paracentesis to meet demands per guidelines &#40;6&#8211;8 g&#47;L of fluid removal&#41; makes albumin therapy after paracentesis an expensive intervention&#46; Cost-effective alternatives to albumins like artificial colloid volume expanders and vasoconstrictors have been investigated&#46; Despite numerous randomized trials&#44; it remains uncertain whether the effectiveness of such alternative treatments is comparable to that of albumin&#46; This uncertainty&#44; partly&#44; reflects the limited statistical power of the randomized trials&#46; Quantitatively combining results of all relevant trials by meta&#8208;analysis could help in resolving the uncertainty&#46; Most recently a meta-analysis by K&#252;tting et&#160;al&#46; &#40;2016&#41; failed to show benefit in clinical endpoints including mortality <a class="elsevierStyleCrossRef" href="#bib0009">&#91;9&#93;</a>&#46; Furthermore&#44; two large randomized controlled trials have been published since 2016 &#91;<a class="elsevierStyleCrossRef" href="#bib0010">10</a>&#44;<a class="elsevierStyleCrossRef" href="#bib0011">11</a>&#93;&#46; Thus&#44; to fully appraise the available data&#44; we sought to perform this systematic review and meta-analysis including 21 trials in 1584 patients with cirrhotic ascites&#46;</p></span><span id="sec0002" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">2</span><span class="elsevierStyleSectionTitle" id="cesectitle0005">Methods</span><p id="para0014" class="elsevierStylePara elsevierViewall">We used PRISMA for the systemic review of available literature <a class="elsevierStyleCrossRef" href="#bib0012">&#91;12&#93;</a>&#46; Our meta-analysis protocol was registered in Prospero &#40;CRD42020223464&#41; <a class="elsevierStyleCrossRef" href="#bib0013">&#91;13&#93;</a>&#46;</p><span id="sec0003" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">2&#46;1</span><span class="elsevierStyleSectionTitle" id="cesectitle0006">Types of studies</span><p id="para0015" class="elsevierStylePara elsevierViewall">All randomized controlled trials &#40;RCTs&#41; published till 18 May 2021 comparing efficacy and safety of human albumin with other volume expanders and vasoactive agents following paracentesis in patients with ascites due to cirrhosis were included&#46; Non-RCTs&#44; Editorials&#44; Commentaries&#44; Viewpoint articles with no proper data of human albumin treatment in patients with ascites due to cirrhosis were excluded&#46;</p></span><span id="sec0004" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">2&#46;2</span><span class="elsevierStyleSectionTitle" id="cesectitle0007">Types of participant</span><p id="para0016" class="elsevierStylePara elsevierViewall">The study included all the adult patients &#40;&#8805; 18 years old&#41; diagnosed with tense and&#47;or refractory ascites due to cirrhosis&#46;</p></span><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">2&#46;3</span><span class="elsevierStyleSectionTitle" id="cesectitle0008">Types of intervention</span><p id="para0017" class="elsevierStylePara elsevierViewall">We included studies where human serum albumin was administered following paracentesis in the patients with tense and&#47;or refractory ascites due to cirrhosis&#46;</p></span><span id="sec0006" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">2&#46;4</span><span class="elsevierStyleSectionTitle" id="cesectitle0009">Comparator</span><p id="para0018" class="elsevierStylePara elsevierViewall">Comparators were placebo&#44; standard care of management &#40;diuretic therapy&#44; and sodium restriction&#44; and use of vasoconstrictors or other volume expanders after therapeutic paracentesis&#41;&#46;</p></span><span id="sec0007" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">2&#46;5</span><span class="elsevierStyleSectionTitle" id="cesectitle0010">Types of outcome measures</span><p id="para0019" class="elsevierStylePara elsevierViewall">Our outcomes were incidence of paracentesis induced circulatory dysfunction&#44; mortality&#44; mean arterial pressure &#40;MAP&#41; at 3&#8211;4 days of treatment&#44; hyponatremia&#44; the reappearance of ascites&#44; hospital readmission&#44; and complications like hepatic encephalopathy&#44; renal impairment&#44; and gastrointestinal bleeding&#46;</p></span><span id="sec0008" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">2&#46;6</span><span class="elsevierStyleSectionTitle" id="cesectitle0011">Search methods for identification of studies</span><p id="para0020" class="elsevierStylePara elsevierViewall">Published papers were screened by two authors based on inclusion and exclusion criteria using Covidence <a class="elsevierStyleCrossRef" href="#bib0014">&#91;14&#93;</a>&#46; Any possible conflicts were resolved by a third member&#46;</p><span id="sec0009" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">2&#46;6&#46;1</span><span class="elsevierStyleSectionTitle" id="cesectitle0012">Electronic searches</span><p id="para0021" class="elsevierStylePara elsevierViewall">We have included the electronic search strategy in Supplementary file 1&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">2&#46;6&#46;2</span><span class="elsevierStyleSectionTitle" id="cesectitle0013">Data collection and analysis</span><p id="para0022" class="elsevierStylePara elsevierViewall">Databases like PubMed&#44; PMC&#44; Scopus&#44; and Embase were searched using appropriate Boolean with no language restriction&#46; We extracted the data onto a standardized form designed in Microsoft Excel-13&#46;</p></span><span id="sec0011" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">2&#46;6&#46;3</span><span class="elsevierStyleSectionTitle" id="cesectitle0014">Selection of studies</span><p id="para0023" class="elsevierStylePara elsevierViewall">We included studies comparing the efficacy and safety of human albumin treatment with outcomes of our interest in patients with ascites due to cirrhosis following paracentesis&#46; We included studies that had both treatment and control groups&#46; The treatment group was comprised of patients with liver cirrhosis and ascites who were treated with albumin after paracentesis and the control group was comprised of patients with liver cirrhosis and ascites who received paracentesis followed by standard medical treatments either placebo or vasoconstrictors or other volume expanders&#46; Editorials&#44; Commentaries&#44; Viewpoint articles with no proper data of human albumin treatment in patients with ascites due to cirrhosis were excluded&#46;</p></span></span><span id="sec0012" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">2&#46;7</span><span class="elsevierStyleSectionTitle" id="cesectitle0015">Data extraction and management</span><p id="para0024" class="elsevierStylePara elsevierViewall">We evaluated the quality of studies and included the outcome in the qualitative and quantitative synthesis&#46;</p><span id="sec0013" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">2&#46;7&#46;1</span><span class="elsevierStyleSectionTitle" id="cesectitle0016">Assessment of risk of bias in included studies</span><p id="para0025" class="elsevierStylePara elsevierViewall">We used Cochrane ROB 2&#46;0 to assess the risk of bias for Trials &#40;<a class="elsevierStyleCrossRef" href="#fig0001">Fig&#46;&#160;1</a>&#46;&#41; <a class="elsevierStyleCrossRef" href="#bib0015">&#91;15&#93;</a>&#46;</p><elsevierMultimedia ident="fig0001"></elsevierMultimedia></span><span id="sec0014" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">2&#46;7&#46;2</span><span class="elsevierStyleSectionTitle" id="cesectitle0017">Assessment of heterogeneity</span><p id="para0026" class="elsevierStylePara elsevierViewall">We assessed the heterogeneity using the I-squared &#40;<span class="elsevierStyleItalic">I</span><span class="elsevierStyleSup">2</span>&#41; test&#46; We used the Cochrane Handbook for Systematic Reviews of Interventions for interpretation of I<span class="elsevierStyleSup">2</span> test done as follows based on 0&#8211;40&#37;&#58; might not be important&#59; 30&#8211;60&#37; may represent moderate heterogeneity&#59; 50&#8211;90&#37;&#58; may represent substantial heterogeneity&#59; 75&#37; to 100&#37;&#58; considerable heterogeneity <a class="elsevierStyleCrossRef" href="#bib0016">&#91;16&#93;</a>&#46; The importance of the observed value of I<span class="elsevierStyleSup">2</span> depends on the magnitude and direction of effects and the strength of evidence for heterogeneity&#46;</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">2&#46;7&#46;3</span><span class="elsevierStyleSectionTitle" id="cesectitle0018">Data synthesis</span><p id="para0027" class="elsevierStylePara elsevierViewall">RevMan 5&#46;4 was used for data synthesis <a class="elsevierStyleCrossRef" href="#bib0017">&#91;17&#93;</a>&#46; Odds ratio &#40;OR&#41; and mean difference was used to estimate the outcome with a 95&#37; confidence interval &#40;CI&#41; where appropriate&#44; and heterogeneity was measured using <span class="elsevierStyleItalic">I</span>&#178;-test&#46; We analyzed the mean difference between two groups&#44; one receiving albumin and the other receiving other treatment for an outcome like mean arterial pressure after 3&#8211;4 days of treatment <a class="elsevierStyleCrossRef" href="#bib0018">&#91;18&#93;</a>&#46; Further sensitivity analysis was performed based on time-frame &#40;studies published before 2000 vs&#46; after 2000&#41; for main outcomes &#40;PICD&#44; mortality&#44; MAP&#44; and hyponatremia&#41;&#46;</p></span></span></span><span id="sec0016" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">3</span><span class="elsevierStyleSectionTitle" id="cesectitle0019">Results</span><p id="para0028" class="elsevierStylePara elsevierViewall">We identified 19482 studies after thorough database searching&#46; After the removal of 3543 duplicates&#44; we screened the title and abstract of 15939 studies and excluded 15823 studies&#46; A total of 116 studies were assessed for full-text eligibility and we excluded 95 studies with definite reasons &#40;<a class="elsevierStyleCrossRef" href="#fig0002">Fig&#46;&#160;2</a>&#41;&#46; We included 21 studies in our qualitative and quantitative analysis &#40;<a class="elsevierStyleCrossRef" href="#tbl0001">Table&#160;1</a>&#41;&#46; Basic features of included studies are presented in Supplementary file 2 &#40;Tables 1 and 2&#41;&#46;</p><elsevierMultimedia ident="fig0002"></elsevierMultimedia><elsevierMultimedia ident="tbl0001"></elsevierMultimedia><span id="sec0017" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">3&#46;1</span><span class="elsevierStyleSectionTitle" id="cesectitle0020">Quantitative synthesis</span><p id="para0029" class="elsevierStylePara elsevierViewall">A total of 21 RCTs in 1584 patients were included in the analysis&#46;</p><span id="sec0018" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">3&#46;1&#46;1</span><span class="elsevierStyleSectionTitle" id="cesectitle0021">Paracentesis induced circulatory dysfunction &#40;PICD&#41;</span><p id="para0030" class="elsevierStylePara elsevierViewall">Nine RCTs reported PICD as an outcome in their study&#46; Overall use of albumin has reduced the odds of PICD by 60&#37; &#40;OR 0&#46;40&#44; 95&#37; CI 0&#46;27&#8211;0&#46;58&#59; <span class="elsevierStyleItalic">n</span>&#160;&#61;&#160;729&#59; <span class="elsevierStyleItalic">I</span><span class="elsevierStyleSup">2</span>&#160;&#61;&#160;0&#37;&#41;&#46; Further analysis showed albumin was superior to other volume expanders in terms of reducing PICD &#40;OR 0&#46;34&#44; 95&#37; CI 0&#46;22&#8211;0&#46;52&#59; <span class="elsevierStyleItalic">n&#160;&#61;</span>&#160;606&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41;&#44; while comparing albumin with vasoconstrictor therapy did not reach statistical significance &#40;OR 0&#46;93&#44; 95&#37; CI 0&#46;35&#8211;2&#46;45&#59; <span class="elsevierStyleItalic">n&#160;&#61;</span>&#160;123&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41; &#40;<a class="elsevierStyleCrossRef" href="#fig0003">Fig&#46;&#160;3</a>&#46;&#41;&#46;</p><elsevierMultimedia ident="fig0003"></elsevierMultimedia><p id="para0031" class="elsevierStylePara elsevierViewall">Further pooling of data on PICD based on time frame using fixed effect model showed significant reduction in odds of PICD in albumin group among studies published before 2000 &#40;OR 0&#46;32&#44; 95&#37; CI 0&#46;19&#8211;0&#46;54&#59; <span class="elsevierStyleItalic">n&#160;&#61;</span>&#160;364&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>43&#37;&#41;&#44; and after 2000 &#40;OR 0&#46;50&#44; 95&#37; CI 0&#46;29&#8211;0&#46;87&#59; <span class="elsevierStyleItalic">n</span>&#160;&#61;&#160;365&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41; &#40;Supplementary file 3&#44; Fig&#46; 1&#41;&#46;</p></span><span id="sec0019" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">3&#46;1&#46;2</span><span class="elsevierStyleSectionTitle" id="cesectitle0022">Mortality outcome</span><p id="para0032" class="elsevierStylePara elsevierViewall">Thirteen studies reported the mortality as an outcome during the study period and follow up&#46; Analysis showed some reduction in overall odds of mortality using albumin therapy but did not reach statistical significance &#40;OR 0&#46;72&#44; 95&#37; CI 0&#46;50&#8211;1&#46;03&#59; <span class="elsevierStyleItalic">n&#160;&#61;</span>&#160;1129&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41;&#46; Further analysis comparing albumin therapy with vasoconstrictor agents &#40;OR 0&#46;84&#44; 95&#37; CI 0&#46;26&#8211;2&#46;67&#59; <span class="elsevierStyleItalic">n&#160;&#61;</span>&#160;140&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41; and placebo or standard medical therapy &#40;SMT&#41; &#40;OR 1&#46;26&#44; 95&#37; CI 0&#46;61&#8211;2&#46;57&#59; <span class="elsevierStyleItalic">n&#160;&#61;</span>&#160;218&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41; showed no significant differences of using albumin therapy over others&#46; But&#44; use of albumin showed a 43&#37; lower odds of mortality compared to other volume expanders &#40;OR 0&#46;57&#44; 95&#37; CI 0&#46;36&#8211;0&#46;89&#59; <span class="elsevierStyleItalic">n&#160;&#61;</span>&#160;771&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41; &#40;<a class="elsevierStyleCrossRef" href="#fig0004">Fig&#46;&#160;4</a>&#41;&#46;</p><elsevierMultimedia ident="fig0004"></elsevierMultimedia><p id="para0033" class="elsevierStylePara elsevierViewall">Further pooling of data on the mortality outcome during the study period and follow up based on time frame using fixed effect model showed some reduction in mortality in the albumin group but it could not reach the level of significance among studies published before 2000 &#40;OR 0&#46;78&#44; 95&#37; CI 0&#46;50&#8211;1&#46;23&#59; <span class="elsevierStyleItalic">n&#160;&#61;</span>&#160;618&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41;&#44; and after 2000 &#40;OR 0&#46;64&#44; 95&#37; CI 0&#46;36&#8211;1&#46;13&#59; n&#160;&#61;&#160;511&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41; &#40;Supplementary file 3&#44; Fig&#46; 2&#41;&#46;</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">3&#46;1&#46;3</span><span class="elsevierStyleSectionTitle" id="cesectitle0023">Re-appearance of ascites</span><p id="para0034" class="elsevierStylePara elsevierViewall">Analysis from pooled data from 5 studies showed no significant reduction in the reappearance of ascites in albumin-treated patients compared to patients receiving other interventions &#40;OR 0&#46;82&#44; 95&#37; CI 0&#46;51&#8211;1&#46;32&#59; <span class="elsevierStyleItalic">n&#160;&#61;</span>&#160;392&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41; &#40;<a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46;&#160;5</a>&#41;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia></span><span id="sec0021" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">3&#46;1&#46;4</span><span class="elsevierStyleSectionTitle" id="cesectitle0024">Hospital readmission</span><p id="para0035" class="elsevierStylePara elsevierViewall">Pooling data from seven studies showed that the use of albumn therapy did not reach statistical significance for hospital readmission while comparing with other therapies &#40;OR 0&#46;75&#44; 95&#37; CI 0&#46;54&#8211;1&#46;05&#59; <span class="elsevierStyleItalic">n&#160;&#61;</span>&#160;591&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41;&#46; Comparing albumin therapy with other volume expanders &#40;OR 0&#46;79&#44; 95&#37; CI 0&#46;53&#8211;1&#46;17&#59; <span class="elsevierStyleItalic">n&#160;&#61;</span>&#160;414&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41;&#44; and SMT &#40;OR 0&#46;67&#44; 95&#37; CI 0&#46;36&#8211;1&#46;25&#59; <span class="elsevierStyleItalic">n&#160;&#61;</span>&#160;177&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41; did not show a significant reduction in readmission either &#40;<a class="elsevierStyleCrossRef" href="#fig0006">Fig&#46;&#160;6</a>&#41;&#46;</p><elsevierMultimedia ident="fig0006"></elsevierMultimedia></span><span id="sec0022" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">3&#46;1&#46;5</span><span class="elsevierStyleSectionTitle" id="cesectitle0025">Mean arterial pressure &#40;MAP&#41; after 4&#8211;6 days of therapy</span><p id="para0036" class="elsevierStylePara elsevierViewall">Analysis taking data of 18 studies reporting MAP did not show significant differences in MAP between albumin and other treatment groups &#40;MD -0&#46;06&#44; 95&#37; CI -1&#46;23 to 1&#46;10&#59; <span class="elsevierStyleItalic">n</span>&#160;&#61;&#160;1194&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>93&#37;&#41;&#46; Further analysis considering type of the control therapy also did not show significant differences in MAP among albumin group over other volume expanders &#40;MD 0&#46;32&#44; 95&#37; CI -1&#46;23 to 1&#46;86&#59; <span class="elsevierStyleItalic">n&#160;&#61;</span>&#160;787&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>93&#37;&#41;&#59; vasoconstrictor agents use &#40;MD 1&#46;02&#44; 95&#37; CI -0&#46;58 to 2&#46;62&#59; <span class="elsevierStyleItalic">n&#160;&#61;</span>&#160;174&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41;&#59; and SMT &#40;MD -1&#46;37&#44; 95&#37; CI -7&#46;48 to 4&#46;73&#59; <span class="elsevierStyleItalic">n&#160;&#61;</span>&#160;233&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>97&#37;&#41; &#40;<a class="elsevierStyleCrossRef" href="#fig0007">Fig&#46;&#160;7</a>&#41;&#46;</p><elsevierMultimedia ident="fig0007"></elsevierMultimedia><p id="para0037" class="elsevierStylePara elsevierViewall">Further pooling of data in MAP based on time frame using random-effect model among studies published before 2000 showed no significant differences in MAP between albumin and other treatment groups &#40;MD -1&#46;41&#44; 95&#37; CI -3&#46;28 to 0&#46;45&#59; <span class="elsevierStyleItalic">n&#160;&#61;</span>&#160;594&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>95&#37;&#41;&#44; however among studies published after 2000 there were some but significantly higher MAP after 4&#8211;6 days of therapy in albumin group &#40;MD 1&#46;82&#44; 95&#37; CI 1&#46;44 to 2&#46;20&#59; <span class="elsevierStyleItalic">n&#160;&#61;</span>&#160;600&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41; &#40;Supplementary file 3&#44; Fig&#46; 3&#41;&#46;</p></span><span id="sec0023" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">3&#46;1&#46;6</span><span class="elsevierStyleSectionTitle" id="cesectitle0026">Hyponatremia</span><p id="para0038" class="elsevierStylePara elsevierViewall">Among 13 studies reporting hyponatremia outcome&#44; pooling of the data showed overall significant low incidence of hyponatremia among albumin treated group than other treatment &#40;OR 0&#46;59&#44; 95&#37; CI 0&#46;39&#8211;0&#46;88&#59; <span class="elsevierStyleItalic">n&#160;&#61;</span>&#160;1058&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41;&#46; On further analysis&#44; there was significant reduction of incidence of hyponatremia in patients recieving albumin therapy as compared to SMT &#40;OR 0&#46;24&#44; 95&#37; CI 0&#46;08&#8211;0&#46;74&#59; <span class="elsevierStyleItalic">n&#160;&#61;</span>&#160;212&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41;&#44; but was not statistically significant while comparing with volume expanders &#40;OR 0&#46;66&#44; 95&#37; CI 0&#46;41&#8211;1&#46;06&#59; <span class="elsevierStyleItalic">n&#160;&#61;</span>&#160;763&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41; or vasopressor group &#40;OR 0&#46;92&#44; 95&#37; CI 0&#46;27&#8211;3&#46;11&#59; <span class="elsevierStyleItalic">n</span>&#160;&#61;&#160;83&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41; &#40;<a class="elsevierStyleCrossRef" href="#fig0008">Fig&#46;&#160;8</a>&#46;&#41;&#46;</p><elsevierMultimedia ident="fig0008"></elsevierMultimedia><p id="para0039" class="elsevierStylePara elsevierViewall">Further pooling of data for hyponatremia outcome based on time frame using fixed effect model among studies published before 2000 showed significantly lower incidence of hyponatremia among albumin treated group than other treatment &#40;OR 0&#46;57&#44; 95&#37; CI 0&#46;35&#8211;0&#46;93&#59; <span class="elsevierStyleItalic">n</span>&#160;&#61;&#160;672&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41;&#44; however&#44; among studies published after 2000&#44; there was some lower odds of hyponatremia in albumin group but could not reach the level of significance &#40;OR 0&#46;63&#44; 95&#37; CI 0&#46;30&#8211;1&#46;32&#59; <span class="elsevierStyleItalic">n</span>&#160;&#61;&#160;386&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41; &#40;Supplementary file 3&#44; Fig&#46; 4&#41;&#46;</p></span><span id="sec0024" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">3&#46;1&#46;7</span><span class="elsevierStyleSectionTitle" id="cesectitle0027">Renal impairment</span><p id="para0040" class="elsevierStylePara elsevierViewall">Overall incidence of renal impairment was not statistically significant between albumin and other therapy &#40;OR 0&#46;76&#44; 95&#37; CI 0&#46;46&#8211;1&#46;25&#59; <span class="elsevierStyleItalic">n</span>&#160;&#61;&#160;1048&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41;&#46; On further analysis&#44; there was no significant reduction in incidence of renal impairment in patients treated with albumin as compared with other volume expanders &#40;OR 1&#46;06&#44; 95&#37; CI 0&#46;59&#8211;1&#46;92&#59; <span class="elsevierStyleItalic">n&#160;&#61;</span>&#160;771&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41;&#44; and SMT &#40;OR 1&#46;57&#44; 95&#37; CI 0&#46;55&#8211;4&#46;47&#59; <span class="elsevierStyleItalic">n&#160;&#61;</span>&#160;181&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41; &#40;<a class="elsevierStyleCrossRef" href="#fig0009">Fig&#46;&#160;9</a>&#46;&#41;&#46;</p><elsevierMultimedia ident="fig0009"></elsevierMultimedia></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">3&#46;1&#46;8</span><span class="elsevierStyleSectionTitle" id="cesectitle0028">Hepatic encephalopathy &#40;HE&#41;</span><p id="para0041" class="elsevierStylePara elsevierViewall">Overall hepatic encephalopathy incidence among albumin and other treatment group was reported in ten studies&#46; Pooling of the data showed no significant differences among albumin and other treatment for incidence of HE &#40;OR 1&#46;05&#44; 95&#37; CI 0&#46;62&#8211;1&#46;77&#59; <span class="elsevierStyleItalic">n&#160;&#61;</span>&#160;916&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41;&#46; Further contrasting albumin with other volume expanders &#40;OR 0&#46;91&#44; 95&#37; CI 0&#46;49&#8211;1&#46;67&#59; <span class="elsevierStyleItalic">n&#160;&#61;</span>&#160;735&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41;&#44; and SMT &#40;OR 1&#46;57&#44; 95&#37; CI 0&#46;55&#8211;4&#46;47&#59; <span class="elsevierStyleItalic">n&#160;&#61;</span>&#160;181&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41; was not statistically significant &#40;<a class="elsevierStyleCrossRef" href="#fig0010">Fig&#46;&#160;10</a>&#41;&#46;</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia></span><span id="sec0026" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">3&#46;1&#46;9</span><span class="elsevierStyleSectionTitle" id="cesectitle0029">Gastrointestinal &#40;GI&#41; bleeding</span><p id="para0042" class="elsevierStylePara elsevierViewall">Overall nine papers reported GI bleeding&#46; Pooling of the data showed no significant differences between using albumin or other therapies &#40;OR 0&#46;98&#44; 95&#37; CI 0&#46;52&#8211;1&#46;86&#59; <span class="elsevierStyleItalic">n&#160;&#61;</span>&#160;912&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41;&#46; Further analysis comparing albumin with other volume expanders &#40;OR 0&#46;97&#44; 95&#37; CI 0&#46;48&#8211;1&#46;99&#59; <span class="elsevierStyleItalic">n</span>&#160;&#61;&#160;694&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41;&#44; and SMT &#40;OR 1&#46;01&#44; 95&#37; CI 0&#46;25&#8211;4&#46;15&#59; <span class="elsevierStyleItalic">n&#160;&#61;</span>&#160;218&#59; <span class="elsevierStyleItalic">I<span class="elsevierStyleSup">2&#160;&#61;</span></span>0&#37;&#41; also did not showed significant differences in GI bleeding &#40;<a class="elsevierStyleCrossRef" href="#fig0011">Fig&#46;&#160;11</a>&#46;&#41;&#46;</p><elsevierMultimedia ident="fig0011"></elsevierMultimedia></span><span id="sec0027" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">3&#46;1&#46;10</span><span class="elsevierStyleSectionTitle" id="cesectitle0030">Publication bias</span><p id="para0043" class="elsevierStylePara elsevierViewall">Funnel plots were used to evaluate the publication bias across the studied outcomes&#46; Among the studied outcomes&#44; there was no significant publication bias except the MAP outcome&#46; Publication bias was not significant in outcomes like overall mortality outcome suggested by symmetry of plot &#40;<a class="elsevierStyleCrossRef" href="#fig0012">Fig&#46;&#160;12</a>&#41;&#44; however significant publication bias was observed for MAP outcome as suggested by the asymmetry of the plot &#40;<a class="elsevierStyleCrossRef" href="#fig0013">Fig&#46;&#160;13</a>&#41;&#46;</p><elsevierMultimedia ident="fig0012"></elsevierMultimedia><elsevierMultimedia ident="fig0013"></elsevierMultimedia></span></span></span><span id="sec0028" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">4</span><span class="elsevierStyleSectionTitle" id="cesectitle0031">Discussions</span><p id="para0044" class="elsevierStylePara elsevierViewall">In this systematic review and meta-analysis&#44; we have compared albumin to alternative treatment modalities including sodium restriction with diuretics&#44; vasoconstrictors &#40;midodrine and octreotide&#41;&#44; and other volume expanders in patients with cirrhotic ascites&#46; The major findings of our study were reduction in paracentesis induced circulatory dysfunction and decrease in hyponatremia with albumin use&#46; Our finding of a reduction in paracentesis induced circulatory dysfunction with albumin by 60&#37; was consistent with the finding of Bernardi et&#160;al <a class="elsevierStyleCrossRef" href="#bib0036">&#91;36&#93;</a>&#46; In a subgroup analysis&#44; we found that albumin was superior to other volume expanders in the prevention of PICD&#46; However&#44; no significant difference was observed between albumin and vasoconstrictors&#46; PICD is regarded as the most significant predictor of mortality in patients with tense ascites that are treated by large-volume paracentesis <a class="elsevierStyleCrossRef" href="#bib0025">&#91;25&#93;</a>&#46; Thus&#44; PICD prevention with albumin is a significant finding of our study&#46; Hyponatremia is an important risk factor for hepatic encephalopathy and a predictor of mortality in patients with cirrhosis &#91;<a class="elsevierStyleCrossRef" href="#bib0037">37</a>&#44;<a class="elsevierStyleCrossRef" href="#bib0038">38</a>&#93;&#46; Thus&#44; the benefit of albumin treatment in the reduction of hyponatremia in patients with cirrhosis and ascites can have implications in reducing hospitalization and long-term clinical outcomes&#46; We found no significant benefits with albumin in preventing recurrence of ascites&#44; renal impairment&#44; hepatic encephalopathy&#44; and GI bleeding&#44; although the combination of antibiotics and albumin was found to decrease renal function in the study done by Sort et&#160;al <a class="elsevierStyleCrossRef" href="#bib0039">&#91;39&#93;</a>&#46;</p><p id="para0045" class="elsevierStylePara elsevierViewall">Human albumin is extracted from donated blood&#46; Thus&#44; there are concerns regarding supply&#44; demand mismatch&#44; and added cost of care with albumin use&#46; Caraceni et&#160;al&#46; suggested albumin as a more cost-effective alternative due to the reduction in readmission rate&#46; However&#44; we found no difference in readmission rates between albumin and standard medical treatment groups <a class="elsevierStyleCrossRef" href="#bib0040">&#91;40&#93;</a>&#46;</p><p id="para0046" class="elsevierStylePara elsevierViewall">Our meta-analysis is the most comprehensive to date to evaluate the efficacy and safety of albumin in patients with cirrhotic ascites&#46; The inclusion of 21 trials in the analysis adds to the power of the study&#46; We compared albumin treatment to various other modalities separately in our analyses&#46; However&#44; our study has limitations&#46; Most of the included trials are small in size and lack statistical power and carry inherent limitations&#46; There was wide variation in inpatient population&#44; treatment dose&#44; and duration of albumin&#44; and endpoints of various studies&#46; Moreover&#44; studies were conducted over a wide period over three decades&#46; There has been substantial evolution in evidence and practice patterns over the past three decades which could have affected the results pertaining to clinical outcomes&#46;</p></span><span id="sec0029" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">5</span><span class="elsevierStyleSectionTitle" id="cesectitle0032">Conclusion</span><p id="para0047" class="elsevierStylePara elsevierViewall">Treatment with albumin in cirrhotic ascites reduced paracentesis-induced circulatory dysfunction and hyponatremia compared to alternative treatment modalities&#46; There was no benefit in mortality&#44; hospital readmission&#44; hepatic encephalopathy&#44; and recurrence of refractory ascites with albumin treatment&#46;</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0033">Declarations</span><p id="para0048" class="elsevierStylePara elsevierViewall">Ethics approval and consent to participate Not applicable</p><p id="para0049" class="elsevierStylePara elsevierViewall">Consent for publication Not applicable</p><p id="para0050" class="elsevierStylePara elsevierViewall">Availability of data and materials the datasets analyzed during the current study are available from the corresponding author on reasonable request&#46;</p><p id="para0051" class="elsevierStylePara elsevierViewall">Funding This article did not receive any specific grant from funding agencies in the public&#44; commercial&#44; or any other sectors&#46;</p><p id="para0052" class="elsevierStylePara elsevierViewall">Authors&#39; contributions&#58; DBS&#44; PB&#44; YRS&#44; RB and MGK contributed to the concept and design&#44; analysis&#44; and interpretation of data&#46; DBS&#44; PB&#44; SA&#44; JY&#44; and LA contributed to the literature search&#44; data extraction&#44; review and initial manuscript drafting&#46; YRS&#44; RB&#44; BD&#44; MGK&#44; and CAC interpretation of data&#44; revising the manuscript for important intellectual content and approval of the final manuscript&#46;</p><p id="para0053" class="elsevierStylePara elsevierViewall">All authors were involved in drafting and revising the manuscript and approved the final version&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:10 [
        0 => array:3 [
          "identificador" => "xres1761527"
          "titulo" => "Abstract"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abss0001"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec1549120"
          "titulo" => "Keywords"
        ]
        2 => array:2 [
          "identificador" => "xpalclavsec1549121"
          "titulo" => "Abbreviations"
        ]
        3 => array:2 [
          "identificador" => "sec0001"
          "titulo" => "Introduction"
        ]
        4 => array:3 [
          "identificador" => "sec0002"
          "titulo" => "Methods"
          "secciones" => array:7 [
            0 => array:2 [
              "identificador" => "sec0003"
              "titulo" => "Types of studies"
            ]
            1 => array:2 [
              "identificador" => "sec0004"
              "titulo" => "Types of participant"
            ]
            2 => array:2 [
              "identificador" => "sec0005"
              "titulo" => "Types of intervention"
            ]
            3 => array:2 [
              "identificador" => "sec0006"
              "titulo" => "Comparator"
            ]
            4 => array:2 [
              "identificador" => "sec0007"
              "titulo" => "Types of outcome measures"
            ]
            5 => array:3 [
              "identificador" => "sec0008"
              "titulo" => "Search methods for identification of studies"
              "secciones" => array:3 [
                0 => array:2 [
                  "identificador" => "sec0009"
                  "titulo" => "Electronic searches"
                ]
                1 => array:2 [
                  "identificador" => "sec0010"
                  "titulo" => "Data collection and analysis"
                ]
                2 => array:2 [
                  "identificador" => "sec0011"
                  "titulo" => "Selection of studies"
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "sec0012"
              "titulo" => "Data extraction and management"
              "secciones" => array:3 [
                0 => array:2 [
                  "identificador" => "sec0013"
                  "titulo" => "Assessment of risk of bias in included studies"
                ]
                1 => array:2 [
                  "identificador" => "sec0014"
                  "titulo" => "Assessment of heterogeneity"
                ]
                2 => array:2 [
                  "identificador" => "sec0015"
                  "titulo" => "Data synthesis"
                ]
              ]
            ]
          ]
        ]
        5 => array:3 [
          "identificador" => "sec0016"
          "titulo" => "Results"
          "secciones" => array:1 [
            0 => array:3 [
              "identificador" => "sec0017"
              "titulo" => "Quantitative synthesis"
              "secciones" => array:10 [
                0 => array:2 [
                  "identificador" => "sec0018"
                  "titulo" => "Paracentesis induced circulatory dysfunction &#40;PICD&#41;"
                ]
                1 => array:2 [
                  "identificador" => "sec0019"
                  "titulo" => "Mortality outcome"
                ]
                2 => array:2 [
                  "identificador" => "sec0020"
                  "titulo" => "Re-appearance of ascites"
                ]
                3 => array:2 [
                  "identificador" => "sec0021"
                  "titulo" => "Hospital readmission"
                ]
                4 => array:2 [
                  "identificador" => "sec0022"
                  "titulo" => "Mean arterial pressure &#40;MAP&#41; after 4&#8211;6 days of therapy"
                ]
                5 => array:2 [
                  "identificador" => "sec0023"
                  "titulo" => "Hyponatremia"
                ]
                6 => array:2 [
                  "identificador" => "sec0024"
                  "titulo" => "Renal impairment"
                ]
                7 => array:2 [
                  "identificador" => "sec0025"
                  "titulo" => "Hepatic encephalopathy &#40;HE&#41;"
                ]
                8 => array:2 [
                  "identificador" => "sec0026"
                  "titulo" => "Gastrointestinal &#40;GI&#41; bleeding"
                ]
                9 => array:2 [
                  "identificador" => "sec0027"
                  "titulo" => "Publication bias"
                ]
              ]
            ]
          ]
        ]
        6 => array:2 [
          "identificador" => "sec0028"
          "titulo" => "Discussions"
        ]
        7 => array:2 [
          "identificador" => "sec0029"
          "titulo" => "Conclusion"
        ]
        8 => array:2 [
          "identificador" => "sec0030"
          "titulo" => "Declarations"
        ]
        9 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2021-04-18"
    "fechaAceptado" => "2021-06-10"
    "PalabrasClave" => array:1 [
      "en" => array:2 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec1549120"
          "palabras" => array:6 [
            0 => "Ascites"
            1 => "Hepatic encephalopathy"
            2 => "Liver cirrhosis"
            3 => "Paracentesis"
            4 => "Serum albumin"
            5 => "Human"
          ]
        ]
        1 => array:4 [
          "clase" => "abr"
          "titulo" => "Abbreviations"
          "identificador" => "xpalclavsec1549121"
          "palabras" => array:11 [
            0 => "AASLD"
            1 => "EASL"
            2 => "GI"
            3 => "HE"
            4 => "HES"
            5 => "HRS"
            6 => "MAP"
            7 => "Na"
            8 => "PAC"
            9 => "PICD"
            10 => "PRA"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:1 [
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abss0001" class="elsevierStyleSection elsevierViewall"><p id="spara016" class="elsevierStyleSimplePara elsevierViewall">Ascites is the most common presentation of decompensated liver cirrhosis&#46; It is treated with therapeutic paracentesis which is associated with several complications&#46; The role of human albumin in patients with cirrhotic ascites remains elusive and has been extensively studied with conflicting results&#46; Thus&#44; in order to fully appraise the available data we sought to perform this systematic review and meta-analysis&#46; Herein we included studies comparing the efficacy and safety of human albumin comparing with other volume expanders and vasoactive agents in patients undergoing paracentesis in cirrhotic ascites&#46; Odds ratio &#40;OR&#41; and mean difference &#40;MD&#41; were used to estimate the outcome with a 95&#37; confidence interval &#40;CI&#41;&#46; Albumin use reduced the odds of paracentesis induced circulatory dysfunction &#40;PICD&#41; by 60&#37; &#40;OR 0&#46;40&#44; 95&#37; CI 0&#46;27&#8211;0&#46;58&#41;&#46; While performing subgroup analysis&#44; albumin use lowered the odds of PICD significantly &#40;OR 0&#46;34&#44; 95&#37; CI 0&#46;22&#8211;0&#46;52&#41; in comparison to other colloid volume expanders&#44; but did not lower the odds of PICD in comparison to vasoconstrictor therapy &#40;OR 0&#46;93&#44; 95&#37; CI 0&#46;35&#8211;2&#46;45&#41;&#46; Albumin was associated with a statistically significant lower incidence of hyponatremia &#40;OR 0&#46;59&#44; 95&#37; CI 0&#46;39&#8211;0&#46;88&#41;&#46; Albumin did not reduce the overall mortality&#44; readmission rate&#44; recurrence of ascites&#44; mean arterial pressure&#44; incidence of renal impairment&#44; hepatic encephalopathy&#44; and gastrointestinal &#40;GI&#41; bleeding&#46; Thus&#44; treatment with albumin in cirrhotic ascites reduced PICD and hyponatremia although there was no benefit in terms of mortality&#44; readmission rate&#44; recurrence of ascites&#44; hepatic encephalopathy&#44; and GI bleeding&#46;</p></span>"
      ]
    ]
    "NotaPie" => array:10 [
      0 => array:3 [
        "etiqueta" => "1"
        "nota" => "<p class="elsevierStyleNotepara" id="notep0001">DBS Medical officer&#44; Department of Emergency Medicine&#44; Mangalbare Hospital&#44; Morang&#44; Nepal</p>"
        "identificador" => "fn1"
      ]
      1 => array:3 [
        "etiqueta" => "2"
        "nota" => "<p class="elsevierStyleNotepara" id="notep0002">Resident Physician&#44; Department of Internal Medicine&#44; Mount Sinai Hospital&#44; Chicago&#44; IL&#44; USA</p>"
        "identificador" => "fn2"
      ]
      2 => array:3 [
        "etiqueta" => "3"
        "nota" => "<p class="elsevierStyleNotepara" id="notep0003">Resident Physician&#44; Department of Internal Medicine&#44; BronxCare Health System&#44; Bronx&#44; NY&#44; USA</p>"
        "identificador" => "fn3"
      ]
      3 => array:3 [
        "etiqueta" => "4"
        "nota" => "<p class="elsevierStyleNotepara" id="notep0004">RB Hospitalist&#44; Our Lady of the Lake Hospital&#44; Baton Rouge LA&#44; USA</p>"
        "identificador" => "fn4"
      ]
      4 => array:3 [
        "etiqueta" => "5"
        "nota" => "<p class="elsevierStyleNotepara" id="notep0005">SA Intern doctor&#44; Nepalese Army Institute of Health Sciences&#44; Kathmandu&#44; Nepal</p>"
        "identificador" => "fn5"
      ]
      5 => array:3 [
        "etiqueta" => "6"
        "nota" => "<p class="elsevierStyleNotepara" id="notep0006">JY Intern doctor&#44; Nepalese Army Institute of Health Sciences&#44; Kathmandu&#44; Nepal</p>"
        "identificador" => "fn6"
      ]
      6 => array:3 [
        "etiqueta" => "7"
        "nota" => "<p class="elsevierStyleNotepara" id="notep0007">LA Medical student&#44; Rangpur Medical College&#44; Bangaladesh</p>"
        "identificador" => "fn7"
      ]
      7 => array:3 [
        "etiqueta" => "8"
        "nota" => "<p class="elsevierStyleNotepara" id="notep0008">BD Assistant Professor&#44; Department of Internal Medicine&#44; Division of Gastroenterology&#44; Virginia Commonwealth University&#44; School of Medicine&#44; Richmond&#44; VA&#44; USA</p>"
        "identificador" => "fn8"
      ]
      8 => array:3 [
        "etiqueta" => "9"
        "nota" => "<p class="elsevierStyleNotepara" id="notep0009">MGK Associate Professor&#59; Department of Internal Medicine&#59; Division of Pulmonary and Critical Care&#44; VCU School of Medicine&#44; Richmond VA&#59; USA</p>"
        "identificador" => "fn9"
      ]
      9 => array:3 [
        "etiqueta" => "10"
        "nota" => "<p class="elsevierStyleNotepara" id="notep0010">CAC Assistant Professor&#44; Department of Pulmonary Disease and Critical Care Medicine&#44; Virginia Commonwealth University&#44; School of Medicine&#44; Richmond&#44; VA&#44; USA</p>"
        "identificador" => "fn10"
      ]
    ]
    "apendice" => array:1 [
      0 => array:1 [
        "seccion" => array:1 [
          0 => array:4 [
            "apendice" => "<p id="para0055a" class="elsevierStylePara elsevierViewall"><elsevierMultimedia ident="ecom0001"></elsevierMultimedia></p>"
            "etiqueta" => "Appendix"
            "titulo" => "Supplementary materials"
            "identificador" => "sec0033"
          ]
        ]
      ]
    ]
    "multimedia" => array:15 [
      0 => array:8 [
        "identificador" => "fig0001"
        "etiqueta" => "Fig&#46; 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 4133
            "Ancho" => 1709
            "Tamanyo" => 809850
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "alt0001"
            "detalle" => "Fig&#46; "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spara001" class="elsevierStyleSimplePara elsevierViewall">ROB 2&#46;0 bias assessment of included studies&#46;</p>"
        ]
      ]
      1 => array:8 [
        "identificador" => "fig0002"
        "etiqueta" => "Fig&#46; 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 2653
            "Ancho" => 2750
            "Tamanyo" => 420714
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "alt0002"
            "detalle" => "Fig&#46; "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spara002" class="elsevierStyleSimplePara elsevierViewall">PRISMA Flow Diagram&#46;</p>"
        ]
      ]
      2 => array:8 [
        "identificador" => "fig0003"
        "etiqueta" => "Fig&#46; 3"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr3.jpeg"
            "Alto" => 1979
            "Ancho" => 3583
            "Tamanyo" => 606239
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "alt0003"
            "detalle" => "Fig&#46; "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spara003" class="elsevierStyleSimplePara elsevierViewall">Forest plot showing PICD rate comparing albumin with other therapy using fixed effect model&#46;</p>"
        ]
      ]
      3 => array:8 [
        "identificador" => "fig0004"
        "etiqueta" => "Fig&#46; 4"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr4.jpeg"
            "Alto" => 2843
            "Ancho" => 3583
            "Tamanyo" => 815800
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "alt0004"
            "detalle" => "Fig&#46; "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spara004" class="elsevierStyleSimplePara elsevierViewall">Forest plot showing mortality outcome comparing albumin with other therapy using fixed effect model&#46;</p>"
        ]
      ]
      4 => array:8 [
        "identificador" => "fig0005"
        "etiqueta" => "Fig&#46; 5"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr5.jpeg"
            "Alto" => 877
            "Ancho" => 3583
            "Tamanyo" => 303067
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "alt0005"
            "detalle" => "Fig&#46; "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spara005" class="elsevierStyleSimplePara elsevierViewall">Forest plot showing re-appearance of ascites comparing albumin with other therapy using fixed effect model&#46;</p>"
        ]
      ]
      5 => array:8 [
        "identificador" => "fig0006"
        "etiqueta" => "Fig&#46; 6"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr6.jpeg"
            "Alto" => 1836
            "Ancho" => 3583
            "Tamanyo" => 564164
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "alt0006"
            "detalle" => "Fig&#46; "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spara006" class="elsevierStyleSimplePara elsevierViewall">Forest plot showing hospital readmission comparing albumin with other therapy using fixed effect model&#46;</p>"
        ]
      ]
      6 => array:8 [
        "identificador" => "fig0007"
        "etiqueta" => "Fig&#46; 7"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr7.jpeg"
            "Alto" => 2723
            "Ancho" => 3583
            "Tamanyo" => 835562
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "alt0007"
            "detalle" => "Fig&#46; "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spara007" class="elsevierStyleSimplePara elsevierViewall">Forest plot showing mean difference on MAP comparing albumin with other therapy using a random-effect model&#46;</p>"
        ]
      ]
      7 => array:8 [
        "identificador" => "fig0008"
        "etiqueta" => "Fig&#46; 8"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr8.jpeg"
            "Alto" => 2991
            "Ancho" => 3583
            "Tamanyo" => 820795
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "alt0008"
            "detalle" => "Fig&#46; "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spara008" class="elsevierStyleSimplePara elsevierViewall">Forest plot showing hyponatremia incidence among albumin and other therapy using fixed effect model&#46;</p>"
        ]
      ]
      8 => array:8 [
        "identificador" => "fig0009"
        "etiqueta" => "Fig&#46; 9"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr9.jpeg"
            "Alto" => 2621
            "Ancho" => 3583
            "Tamanyo" => 754907
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "alt0009"
            "detalle" => "Fig&#46; "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spara009" class="elsevierStyleSimplePara elsevierViewall">Forest plot showing renal impairment among albumin and other therapy using fixed effect model&#46;</p>"
        ]
      ]
      9 => array:8 [
        "identificador" => "fig0010"
        "etiqueta" => "Fig&#46; 10"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr10.jpeg"
            "Alto" => 2201
            "Ancho" => 3583
            "Tamanyo" => 652867
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "alt0010"
            "detalle" => "Fig&#46; 1"
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spara010" class="elsevierStyleSimplePara elsevierViewall">Forest plot showing HE among albumin and other therapy using fixed effect model&#46;</p>"
        ]
      ]
      10 => array:8 [
        "identificador" => "fig0011"
        "etiqueta" => "Fig&#46; 11"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr11.jpeg"
            "Alto" => 2017
            "Ancho" => 3583
            "Tamanyo" => 613103
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "alt0011"
            "detalle" => "Fig&#46; 1"
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spara011" class="elsevierStyleSimplePara elsevierViewall">Forest plot showing GI bleeding among albumin and other therapy using fixed effect model&#46;</p>"
        ]
      ]
      11 => array:8 [
        "identificador" => "fig0012"
        "etiqueta" => "Fig&#46; 12"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr12.jpeg"
            "Alto" => 1806
            "Ancho" => 2583
            "Tamanyo" => 185453
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "alt0012"
            "detalle" => "Fig&#46; 1"
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spara012" class="elsevierStyleSimplePara elsevierViewall">Funnel plot showing the symmetric distribution of studies suggesting no significant publication bias for mortality outcome&#46;</p>"
        ]
      ]
      12 => array:8 [
        "identificador" => "fig0013"
        "etiqueta" => "Fig&#46; 13"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr13.jpeg"
            "Alto" => 1783
            "Ancho" => 2500
            "Tamanyo" => 155791
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "alt0013"
            "detalle" => "Fig&#46; 1"
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spara013" class="elsevierStyleSimplePara elsevierViewall">Funnel plot showing the asymmetric distribution of studies suggesting publication bias for MAP outcome&#46;</p>"
        ]
      ]
      13 => array:8 [
        "identificador" => "tbl0001"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "alt0014"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spara015" class="elsevierStyleSimplePara elsevierViewall">Abbreviations&#58; Alb&#58; Albumin&#44; dl&#58; Deciliter&#44; g&#58; gram&#44; GI&#58; Gastrointestinal&#44; HE&#58; Hepatic Encephalopathy&#44; HES&#58; Hydroxyethyl Starch&#44; hr&#58; Hour&#44; HRS&#58; Hepatorenal Syndrome&#44; IV&#58; Intravenous&#44; L&#58; Liter&#44; MAP&#58; Mean Arterial Pressure&#44; ml&#58; milliliter&#44; N&#58; Sample size&#44; Na&#58; sodium&#44; PAC&#58; Plasma Aldosterone Concentration&#44; Para&#58; Paracentesis&#44; PCD&#58; Paracentesis-induced Circulatory Dysfunction&#44; PRA&#58; Plasma Renin Activity&#44; UOP&#58; urine output&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:1 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><a name="en0001"></a><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">ID&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><a name="en0002"></a><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">Population&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><a name="en0003"></a><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">Intervention&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><a name="en0004"></a><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">Comparisons&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><a name="en0005"></a><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">Outcome&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><a name="en0006"></a><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">Follow Up Period&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><a name="en0007"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Abootalebi A <a class="elsevierStyleCrossRef" href="#bib0010">&#91;10&#93;</a> et&#160;al 2017&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0008"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleItalic">N</span>&#160;&#61;&#160;108&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0009"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Alb&#44; 5 g&#47;L of ascites removed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0010"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">HES&#44; 5 g&#47;L of ascites removedAlb&#43; HES&#44; 2&#46;5 g&#47;L Alb 2&#46;5 g&#47;L HES of ascites removed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0011"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">At day 4&#44; higher MAP in Alb group&#46; No difference in weight&#44; HR&#44; UOP&#44; laboratory values&#44; and LOC&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0012"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0013"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Abdel-Khalek EE <a class="elsevierStyleCrossRef" href="#bib0019">&#91;19&#93;</a> et&#160;al 2010&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0014"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleItalic">N&#160;&#61;</span>&#160;135&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0015"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">20&#37; Alb&#44; 8 g&#47;L of ascites removed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0016"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">HES 6&#37;&#44; 8 g&#47;L of ascites removed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0017"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Postparacentesis transient hypotension significantly worse in HES group&#46; At 6th day&#44; no difference in renal or hepatic function&#44; serum electrolytes&#44; or complications&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0018"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">6-month follow up&#44; no difference in readmissions&#44; complications&#44; or mortality&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0019"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Altman C <a class="elsevierStyleCrossRef" href="#bib0020">&#91;20&#93;</a> et&#160;al 1998&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0020"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleItalic">N&#160;&#61;</span>&#160;60&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0021"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Alb&#44; 20 g if less than 2 L of ascites removed&#59; 40 g if 2-5 L of ascites removed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0022"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">HES group&#44; 32&#46;5 g if less than 2 L of ascites removed&#59; 65 g if 2-5 L of ascites removed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0023"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Day 1&#44; 3&#44; and 15&#44; no difference in development of renal failure or hyponatremia&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0024"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Up to 15 days&#44; no difference in complications&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0025"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Appenrodt <a class="elsevierStyleCrossRef" href="#bib0006">&#91;6&#93;</a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0026"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleItalic">N&#160;&#61;</span>&#160;24&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0027"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Alb&#44; 8 g&#47;L of ascites removed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0028"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Midodrine&#44; 12&#46;5 mg every 8&#160;h for 2 days&#44; six doses each&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0029"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">On day 6&#44; PICD &#40;&#62;50&#37; increase in pre-treatment renin&#41;&#44; 31&#37; &#40;<span class="elsevierStyleItalic">n</span>&#160;&#61;&#160;4&#41; Alb&#44; 60&#37; &#40;<span class="elsevierStyleItalic">n</span>&#160;&#61;&#160;6&#41; midodrine&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0030"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0031"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Bari K <a class="elsevierStyleCrossRef" href="#bib0021">&#91;21&#93;</a> et&#160;al&#46; 2012&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0032"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleItalic">N&#160;&#61;</span>&#160; 25&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0033"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Alb&#44; 8 g&#47;L of ascites removed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0034"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Octreotide long-acting release 20 mg intramuscularly to be repeated every monthMidodrine&#44; 10 mg orally 3 times a day&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0035"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">No significant difference in time to recurrence of ascites&#46;At day 6&#44; no significant difference in PICD&#44; MAP&#44; HR&#44; HRS&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0036"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">10 months&#44; no difference in mortality&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0037"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Fassio E <a class="elsevierStyleCrossRef" href="#bib0022">&#91;22&#93;</a> et&#160;al 1992&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0038"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleItalic">N&#160;&#61;</span>&#160;41&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0039"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Alb&#44; 6 g&#47;L of ascites removed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0040"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Dextran&#44; 6 g&#47;L of ascites removed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0041"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">At 24 hrs and 96 hrs&#44; no significant difference in renal and liver function tests&#44; MAP&#44; or electrolytes&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0042"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Approximately 30 weeks&#44; no different in re-admission and mortality&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0043"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Garcia-Compean D et&#160;al <a class="elsevierStyleCrossRef" href="#bib0023">&#91;23&#93;</a> 1993&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0044"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleItalic">N&#160;&#61;</span>&#160;35&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0045"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Alb&#44; 5 g&#47;L ascites removed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0046"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">No albumin&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0047"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">At 12 hr&#44; there was a significant decrease of CO in the no albumin group&#46; At 6 and 24hrs&#44; there was a significantly reduced PRA in the albumin group&#46; At 1 and 6 hrs&#44; there was a significantly reduced PAC in the albumin group&#46; No difference in complications&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0048"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Frequency of complications after 24 hrs was no different between the groups&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0049"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Garc&#237;a-Compean D <a class="elsevierStyleCrossRef" href="#bib0024">&#91;24&#93;</a> et&#160;al 2002&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0050"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleItalic">N&#160;&#61;</span>&#160;96&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0051"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Alb&#44; 8 g&#47;L of ascites removed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0052"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Dextran-40&#44; 8 g&#47;L of ascites removed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0053"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">At 24 hour and 48 hrs&#44; there was a significant decrease in MAP in both groups&#46; Significant increase in UOP in both groups at 24 hrs&#44; but only remained significant in the albumin group at 48 hrs&#46; At 48 hrs&#44; PRA was significantly higher in the Dextran-40 group&#46; Significantly more PICD in Dextran-40 group&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0054"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Up to 44 months&#44; no significant difference in complications&#44; ascites recurrent rates&#44; or mortality&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0055"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Gines P <a class="elsevierStyleCrossRef" href="#bib0002">&#91;2&#93;</a> et&#160;al 1988&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0056"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleItalic">N&#160;&#61;</span>&#160;105&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0057"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Alb&#44; 40 g post para&#44; 4-6 L ascites removed daily until resolution of ascites&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0058"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">No Alb&#44; 4-6 L ascites removed daily until resolution of ascites&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0059"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Day 6&#44; no significant difference in standard renal function tests&#44; PRA&#44; and PAC&#46; Paracentesis without albumin was associated with a significant increase in BUN&#44; a marked elevation in PRA and PAC&#44; and a significant reduction in serum sodium concentration&#46; No difference in probability of survival&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0060"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Up to 40 weeks no significant reappearance of ascites&#44; readmission or death&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0061"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Gines A <a class="elsevierStyleCrossRef" href="#bib0025">&#91;25&#93;</a> et&#160;al 1996&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0062"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleItalic">N&#160;&#61;</span>&#160;289&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0063"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Alb&#44; 8 g&#47;L of ascites removed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0064"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Dextran70&#44; 8 g&#47;L of ascites removedPolygeline&#44; 8 g&#47;L of ascites removed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0065"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">At day 6&#44; PICD occurred at a significantly greater frequency in the dextran and polygeline groups&#46; Creatinine and PRA increase&#44; and serum sodium decrease was significant in the dextran and polygeline when compared to the alb group&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0066"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Up to 30 months&#44; no difference in readmission or death&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0067"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Khan MU <a class="elsevierStyleCrossRef" href="#bib0026">&#91;26&#93;</a> et&#160;al 2015&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0068"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleItalic">N&#160;&#61;</span>&#160;50&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0069"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Alb&#44; 6 g&#47;L and 125 ml&#47;L fluid of ascites removed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0070"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Hemaccel 6 g&#47;L and 125 ml&#47;L fluid of ascites removed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0071"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">At 6 days&#44; no significant difference in creatinine&#44; sodium&#44; or MAP&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0072"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0073"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Luca A <a class="elsevierStyleCrossRef" href="#bib0027">&#91;27&#93;</a> et&#160;al 1995&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0074"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleItalic">N&#160;&#61;</span>&#160;18&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0075"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Alb&#44; 8g&#47;L of ascites removed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0076"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">No albumin&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0077"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">At 24&#160;h&#44; no significant difference in hemodynamics&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0078"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0079"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Moreau R <a class="elsevierStyleCrossRef" href="#bib0028">&#91;28&#93;</a> et&#160;al 2002&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0080"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleItalic">N&#160;&#61;</span>&#160;20&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0081"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Alb&#44; 8 g&#47;L of ascites removed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0082"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Terlipressin&#44; total dose of 3 mg&#44; administered as 1mg IV at the onset of paracentesis&#44; 8&#160;h and 16&#160;h&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0083"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">At hospital discharge&#44; no significant change in effective arterial blood volume assess by PRC&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0084"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0085"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Moreau R <a class="elsevierStyleCrossRef" href="#bib0029">&#91;29&#93;</a> et&#160;al 2006&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0086"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleItalic">N&#160;&#61;</span>&#160;68&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0087"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Alb&#44; variable dosing&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0088"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Synthetic colloid &#40;3&#46;5&#37; polygeline&#41;&#44; variable dosing&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0089"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Follow up till 6 months&#44; no significant difference in development of at least one liver-related complication or time-to-first complication&#46;The total number of liver&#8208;related complications adjusted to a 100&#8208;day period was significantly lower in the alb group&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0090"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0091"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Planas R <a class="elsevierStyleCrossRef" href="#bib0030">&#91;30&#93;</a> et&#160;al 1990&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0092"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleItalic">N&#160;&#61;</span>&#160;88&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0093"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Alb&#44; 8 g&#47;L of ascites removed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0094"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Dextran-70 8 g&#47;L of ascites removed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0095"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">At day 6&#44; no significant difference in renal and hepatic function or serum electrolytes&#46;A significant increase in PRA and PAC was observed in the Dextran group compared to the Alb group&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0096"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Up to 40 weeks&#44; no significant difference in readmissions or death&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0097"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Salerno F <a class="elsevierStyleCrossRef" href="#bib0031">&#91;31&#93;</a> et&#160;al 1987&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0098"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleItalic">N&#160;&#61;</span>&#160;41&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0099"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Albumin with repeated para&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0100"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Diuretics alone&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0101"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Ascites disappeared within 3 or 4 days with paracentesis&#44; but only after 15 days with diuretics&#46; No negative changes were induced in clinical and laboratory parameters of hemodynamic&#44; hepatic and renal function after evacuation of the ascites&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0102"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Follow-up period for 19&#46;8&#177;2&#46;6 weeks in Alb and 14&#177;2&#46;2 weeks in diuretics&#46;No significant difference in complications or death&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0103"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Salerno F <a class="elsevierStyleCrossRef" href="#bib0032">&#91;33&#93;</a> et&#160;al 1991&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0104"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleItalic">N&#160;&#61;</span>&#160;54&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0105"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Alb&#44; 20&#37; 30mL&#47;L of ascites removed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0106"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Hemaccel 3&#46;5&#37;&#44; 150mL&#47;L of ascites removed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0107"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">At day 1&#44; 3&#44; and 6&#44; hemodynamics&#44; electrolytes&#44; and hormone levels were not significantly different between the groups expect for albumin concentration&#59; significantly higher in the Alb group at day 1&#44; 3&#44; and 6&#41;&#46;No significant difference in complications&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0108"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Up to 172 weeks&#44; probability of recurrence of massive ascites and probability of survival was similar between the two groups&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0109"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Singh V <a class="elsevierStyleCrossRef" href="#bib0033">&#91;33&#93;</a> et&#160;al 2008&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0110"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleItalic">N&#160;&#61;</span>&#160;40&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0111"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Alb&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0112"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Midodrine&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0113"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Plasma renin activity at 6 days after paracentesis did not differ in the two groups&#46; Significant increase in 24-h urine volume and urine sodium excretion in the midodrine group&#46; Midodrine therapy was cheaper than albumin therapy&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0114"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">No difference in repeat para within 3 months of treatment&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0115"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Singh V <a class="elsevierStyleCrossRef" href="#bib0034">&#91;34&#93;</a> et&#160;al 2006&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0116"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleItalic">N&#160;&#61;</span>&#160;40&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0117"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Alb&#44; 8g&#47;L of ascites removed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0118"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Terlipressin&#44; total dose of 3mg&#44; administered as 1mg IV at the onset of paracentesis&#44; 8&#160;h and 16&#160;h&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0119"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">No significant difference in development of PICD&#44; renal impairment or hyponatremia at day 4&#8211;6 post intervention&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0120"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">No difference in repeat para within 3 months of treatment&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0121"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Sola-Vera J <a class="elsevierStyleCrossRef" href="#bib0035">&#91;35&#93;</a> et&#160;al 2003&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0122"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleItalic">N&#160;&#61;</span>&#160;72&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0123"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Alb&#44; 8 g&#47;L of ascites removed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0124"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">IV saline infusion&#44; constant rate via a pump infusion device &#40;170 mL of 3&#46;5&#37; saline solution &#47; L of ascites removed at 999 mL&#47;h&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0125"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">The incidence of PICD was significantly higher in the saline group versus the albumin group&#44; however not significant if less than 6L of ascitic fluid was removed&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0126"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">No significant differences betweenclinical and laboratory data before second paracentesis between the two groups&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0127"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Yosry <a class="elsevierStyleCrossRef" href="#bib0011">&#91;11&#93;</a> A et&#160;al 2018&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0128"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleItalic">N&#160;&#61;</span>&#160;75&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0129"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Alb&#44; 8 g&#47;L of ascites removed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0130"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">2-day midodrine&#44; 12&#46;5mg q8hrs for 2 days30-day midodrine&#44; 12&#46;5mg q8hrs for 30 days&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0131"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">Significant increase in 24&#160;h urine Na excretion and renal perfusion at 30 days in the 30-day midodrine group&#46; Both midodrine groups were significantly lower in cost than Alb&#46; No significant difference in development of renal impairment&#44; hyponatremia&#44; or mortality at day 6 and 30&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0132"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">up to day 30&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spara014" class="elsevierStyleSimplePara elsevierViewall">Qualitative summary of included studies&#46;</p>"
        ]
      ]
      14 => array:6 [
        "identificador" => "ecom0001"
        "tipo" => "MULTIMEDIAECOMPONENTE"
        "mostrarFloat" => false
        "mostrarDisplay" => true
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "alt0015"
            "detalle" => "Image&#44; application "
            "rol" => "short"
          ]
        ]
        "Ecomponente" => array:2 [
          "fichero" => "mmc1.docx"
          "ficheroTamanyo" => 170724
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "cebibsec1"
          "bibliografiaReferencia" => array:40 [
            0 => array:3 [
              "identificador" => "bib0001"
              "etiqueta" => "&#91;1&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Natural history and prognostic indicators of survival in cirrhosis&#58; a systematic review of 118 studies"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "G D&#39;Amico"
                            1 => "G Garcia-Tsao"
                            2 => "L&#46; Pagliaro"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jhep.2005.10.013"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Hepatol"
                        "fecha" => "2006"
                        "volumen" => "44"
                        "paginaInicial" => "217"
                        "paginaFinal" => "231"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16298014"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0002"
              "etiqueta" => "&#91;2&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "P Gin&#232;s"
                            1 => "L Tit&#243;"
                            2 => "V Arroyo"
                            3 => "R Planas"
                            4 => "J Pan&#233;s"
                            5 => "J Viver"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/0016-5085(88)90691-9"
                      "Revista" => array:6 [
                        "tituloSerie" => "Gastroenterology"
                        "fecha" => "1988"
                        "volumen" => "94"
                        "paginaInicial" => "1493"
                        "paginaFinal" => "1502"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/3360270"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0003"
              "etiqueta" => "&#91;3&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Spontaneous bacterial peritonitis in cirrhotic patients&#58; is prophylactic propranolol therapy beneficial&#63;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "E Cholongitas"
                            1 => "G&#46;V&#46; Papatheodoridis"
                            2 => "EK Manesis"
                            3 => "AK Burroughs"
                            4 => "AJ&#46; Archimandritis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1440-1746.2005.03982.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Gastroenterol Hepatol"
                        "fecha" => "2006"
                        "volumen" => "21"
                        "paginaInicial" => "581"
                        "paginaFinal" => "587"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16638103"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0004"
              "etiqueta" => "&#91;4&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Guidelines on the management of ascites in cirrhosis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "KP Moore"
                            1 => "GP&#46; Aithal"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/gut.2006.099580"
                      "Revista" => array:3 [
                        "tituloSerie" => "Gut"
                        "fecha" => "2006"
                        "volumen" => "55"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "&#91;5&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Hemodynamic changes in patients developing effective hypovolemia after total paracentesis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "MC Vila"
                            1 => "R Sol&#224;"
                            2 => "L Molina"
                            3 => "M Andreu"
                            4 => "S Coll"
                            5 => "J Gana"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0168-8278(98)80288-2"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Hepatol"
                        "fecha" => "1998"
                        "volumen" => "28"
                        "paginaInicial" => "639"
                        "paginaFinal" => "645"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9566833"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0006"
              "etiqueta" => "&#91;6&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prevention of paracentesis-induced circulatory dysfunction&#58; midodrine vs albumin&#46; A randomized pilot study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "B Appenrodt"
                            1 => "A Wolf"
                            2 => "F Gr&#252;nhage"
                            3 => "J Trebicka"
                            4 => "M Schepke"
                            5 => "C Rabe"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1478-3231.2008.01734.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Liver Int"
                        "fecha" => "2008"
                        "volumen" => "28"
                        "paginaInicial" => "1019"
                        "paginaFinal" => "1025"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18410283"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0007"
              "etiqueta" => "&#91;7&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The clinical management of abdominal ascites&#44; spontaneous bacterial peritonitis and hepatorenal syndrome&#58; a review of current guidelines and recommendations"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "M Pericleous"
                            1 => "A Sarnowski"
                            2 => "A Moore"
                            3 => "R Fijten"
                            4 => "M&#46; Zaman"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/MEG.0000000000000548"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur J Gastroenterol Hepatol"
                        "fecha" => "2016"
                        "volumen" => "28"
                        "paginaInicial" => "e10"
                        "paginaFinal" => "e18"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26671516"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0008"
              "etiqueta" => "&#91;8&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "BA&#46; Runyon"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/hep.26359"
                      "Revista" => array:6 [
                        "tituloSerie" => "Hepatology"
                        "fecha" => "2013"
                        "volumen" => "57"
                        "paginaInicial" => "1651"
                        "paginaFinal" => "1653"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23463403"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0009"
              "etiqueta" => "&#91;9&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Insufficient evidence of benefit regarding mortality due to albumin substitution in HCC-free cirrhotic patients undergoing large volume paracentesis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "F K&#252;tting"
                            1 => "J Schubert"
                            2 => "J Franklin"
                            3 => "A Bowe"
                            4 => "V Hoffmann"
                            5 => "M Demir"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/jgh.13421"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Gastroenterol Hepatol"
                        "fecha" => "2017"
                        "volumen" => "32"
                        "paginaInicial" => "327"
                        "paginaFinal" => "338"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27149296"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "&#91;10&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Comparing the effects of hydroxyethyl starch and albumin in cirrhotic patients with tense ascites&#59; a randomized clinical trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "A Abootalebi"
                            1 => "S Khazaei"
                            2 => "M Minakari"
                            3 => "M Nasr-Isfahani"
                            4 => "M Esmailian"
                            5 => "F&#46; Heydari"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.22114/AJEM.v1i1.17"
                      "Revista" => array:3 [
                        "tituloSerie" => "Adv J Emerg Med"
                        "fecha" => "2017"
                        "volumen" => "1"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0011"
              "etiqueta" => "&#91;11&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Oral midodrine is comparable to albumin infusion in cirrhotic patients with refractory ascites undergoing large-volume paracentesis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "A Yosry"
                            1 => "ZA Soliman"
                            2 => "R Eletreby"
                            3 => "I Hamza"
                            4 => "A Ismail"
                            5 => "MA&#46; Elkady"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/MEG.0000000000001277"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur J Gastroenterol Hepatol"
                        "fecha" => "2019"
                        "volumen" => "31"
                        "paginaInicial" => "345"
                        "paginaFinal" => "351"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30312183"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0012"
              "etiqueta" => "&#91;12&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions&#58; explanation and elaboration"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A Liberati"
                            1 => "DG Altman"
                            2 => "J Tetzlaff"
                            3 => "C Mulrow"
                            4 => "PC G&#248;tzsche"
                            5 => "JPA Ioannidis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/bmj.b2700"
                      "Revista" => array:4 [
                        "tituloSerie" => "BMJ"
                        "fecha" => "2009"
                        "volumen" => "339"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19574308"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0013"
              "etiqueta" => "&#91;13&#93;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Shrestha D&#44; Budhathoki P&#44; Sedhai YR&#44; Awal S&#44; Yadav J&#44; Awal L&#44; et&#160;al&#46; A meta-analysis of efficacy and safety of human serum albumin treatment in patients with ascites due to cirrhosis&#46; PROSPERO 2020 CRD42020223464 n&#46;d&#46; <a target="_blank" href="https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=223464">https&#58;&#47;&#47;www&#46;crd&#46;york&#46;ac&#46;uk&#47;prospero&#47;display&#95;record&#46;php&#63;RecordID&#61;223464</a> &#40;accessed May 27&#44; 2021 &#41;&#46;"
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0014"
              "etiqueta" => "&#91;14&#93;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "How can I cite Covidence&#63; n&#46;d&#46; <a target="_blank" href="https://support.covidence.org/help/how-can-i-cite-covidence">https&#58;&#47;&#47;support&#46;covidence&#46;org&#47;help&#47;how-can-i-cite-covidence</a> &#40;accessed January 26&#44; 2021 &#41;&#46;"
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "&#91;15&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "RoB 2&#58; a revised tool for assessing risk of bias in randomised trials"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "JAC Sterne"
                            1 => "J Savovi&#263;"
                            2 => "MJ Page"
                            3 => "RG Elbers"
                            4 => "NS Blencowe"
                            5 => "I Boutron"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/bmj.l4898"
                      "Revista" => array:4 [
                        "tituloSerie" => "BMJ"
                        "fecha" => "2019"
                        "volumen" => "366"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31462531"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0016"
              "etiqueta" => "&#91;16&#93;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "9&#46;5&#46;2 Identifying and measuring heterogeneity n&#46;d&#46; <a target="_blank" href="https://handbook-5-1.cochrane.org/chapter_9/9_5_2_identifying_and_measuring_heterogeneity.htm">https&#58;&#47;&#47;handbook-5-1&#46;cochrane&#46;org&#47;chapter&#95;9&#47;9&#95;5&#95;2&#95;identifying&#95;and&#95;measuring&#95;heterogeneity&#46;htm</a> &#40;accessed December 18&#44; 2020&#41;&#46;"
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0017"
              "etiqueta" => "&#91;17&#93;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "RevMan for non-Cochrane reviews &#124; Cochrane Training n&#46;d&#46; <a target="_blank" href="https://training.cochrane.org/online-learning/core-software-cochrane-reviews/revman/revman-non-cochrane-reviews">https&#58;&#47;&#47;training&#46;cochrane&#46;org&#47;online-learning&#47;core-software-cochrane-reviews&#47;revman&#47;revman-non-cochrane-reviews</a> &#40;accessed January 26&#44; 2021&#41;&#46;"
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0018"
              "etiqueta" => "&#91;18&#93;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Mean Variance Estimation n&#46;d&#46; <a target="_blank" href="https://web.archive.org/web/20181224162602/http:/www.comp.hkbu.edu.hk/~xwan/median2mean.html">https&#58;&#47;&#47;web&#46;archive&#46;org&#47;web&#47;20181224162602&#47;http&#58;&#47;www&#46;comp&#46;hkbu&#46;edu&#46;hk&#47;&#8764;xwan&#47;median2mean&#46;html</a> &#40;accessed December 19&#44; 2020&#41;&#46;"
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0019"
              "etiqueta" => "&#91;19&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Randomized trial comparing human albumin and hydroxyethyl starch 6&#37; as plasma expanders for treatment of patients with liver cirrhosis and tense ascites following large volume paracentesis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "EE Abdel-Khalek"
                            1 => "SE&#46; Arif"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.ajg.2010.01.006"
                      "Revista" => array:5 [
                        "tituloSerie" => "Arab J Gastroenterol"
                        "fecha" => "2010"
                        "volumen" => "11"
                        "paginaInicial" => "24"
                        "paginaFinal" => "29"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "&#91;20&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "C Altman"
                            1 => "B Bernard"
                            2 => "D Roulot"
                            3 => "RL Vitte"
                            4 => "O&#46; Ink"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/00042737-199801000-00002"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur J Gastroenterol Hepatol"
                        "fecha" => "1998"
                        "volumen" => "10"
                        "paginaInicial" => "5"
                        "paginaFinal" => "10"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9512946"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib0021"
              "etiqueta" => "&#91;21&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The combination of octreotide and midodrine is not superior to albumin in preventing recurrence of ascites after large-volume paracentesis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "K Bari"
                            1 => "C Mi&#241;ano"
                            2 => "M Shea"
                            3 => "IB Inayat"
                            4 => "HJ Hashem"
                            5 => "HC Gilles"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.cgh.2012.06.027"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Gastroenterol Hepatol"
                        "fecha" => "2012"
                        "volumen" => "10"
                        "paginaInicial" => "1169"
                        "paginaFinal" => "1175"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22801062"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib0022"
              "etiqueta" => "&#91;22&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Paracentesis with Dextran 70 vs&#46; paracentesis with albumin in cirrhosis with tense ascites&#46; Results of a randomized study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "E Fassio"
                            1 => "R Terg"
                            2 => "G Landeira"
                            3 => "R Abecasis"
                            4 => "M Salemne"
                            5 => "A Podesta"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/0168-8278(92)90176-P"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Hepatol"
                        "fecha" => "1992"
                        "volumen" => "14"
                        "paginaInicial" => "310"
                        "paginaFinal" => "316"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1380024"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib0023"
              "etiqueta" => "&#91;23&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Total therapeutic paracentesis &#40;TTP&#41; with and without intravenous albumin in the treatment of cirrhotic tense ascites&#58; a randomized controlled trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "D Garcia-Compe&#225;n"
                            1 => "JZ Villarreal"
                            2 => "HB Cuevas"
                            3 => "DAG Cant&#252;"
                            4 => "M Estrella"
                            5 => "EG Tamez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1600-0676.1993.tb00637.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Liver"
                        "fecha" => "1993"
                        "volumen" => "13"
                        "paginaInicial" => "233"
                        "paginaFinal" => "238"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8259034"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bib0024"
              "etiqueta" => "&#91;24&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis&#58; a randomized controlled trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "D Garc&#237;a-Compean"
                            1 => "P Blanc"
                            2 => "D Larrey"
                            3 => "J-P Daures"
                            4 => "J Hirtz"
                            5 => "E Mendoza"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Ann Hepatol"
                        "fecha" => "2002"
                        "volumen" => "1"
                        "paginaInicial" => "29"
                        "paginaFinal" => "35"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "&#91;25&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Randomized trial comparing albumin&#44; dextran 70&#44; and polygeline in cirrhotic patients with ascites treated by paracentesis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A Gines"
                            1 => "G Fernandez-Esparrach"
                            2 => "A Monescillo"
                            3 => "C Vila"
                            4 => "E Domenech"
                            5 => "R Abecasis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0016-5085(96)70068-9"
                      "Revista" => array:6 [
                        "tituloSerie" => "Gastroenterology"
                        "fecha" => "1996"
                        "volumen" => "111"
                        "paginaInicial" => "1002"
                        "paginaFinal" => "1010"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8831595"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            25 => array:3 [
              "identificador" => "bib0026"
              "etiqueta" => "&#91;26&#93;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Rahim UR&#44; Latif M&#46; Hemaccel as a Cheaper Alternative to Human Albumin for Plasma Expansion during Paracentesis in Cirrhotic patients&#46; n&#46;d&#46;"
                ]
              ]
            ]
            26 => array:3 [
              "identificador" => "bib0027"
              "etiqueta" => "&#91;27&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A Luca"
                            1 => "JC Garc&#237;a-Pag&#225;n"
                            2 => "J Bosch"
                            3 => "F Feu"
                            4 => "W Jim&#233;nez"
                            5 => "A Gin&#233;s"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Hepatology"
                        "fecha" => "1995"
                        "volumen" => "22"
                        "paginaInicial" => "753"
                        "paginaFinal" => "758"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7657279"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            27 => array:3 [
              "identificador" => "bib0028"
              "etiqueta" => "&#91;28&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis&#58; a randomised pilot study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R Moreau"
                            1 => "D Valla"
                            2 => "D Lebrec"
                            3 => "T Asselah"
                            4 => "B Condat"
                            5 => "C De Kerguenec"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/gut.50.1.90"
                      "Revista" => array:6 [
                        "tituloSerie" => "Gut"
                        "fecha" => "2002"
                        "volumen" => "50"
                        "paginaInicial" => "90"
                        "paginaFinal" => "94"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11772973"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            28 => array:3 [
              "identificador" => "bib0029"
              "etiqueta" => "&#91;29&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid&#58; a randomised controlled pilot trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R Moreau"
                            1 => "DC Valla"
                            2 => "I Durand-Zaleski"
                            3 => "JP Bronowicki"
                            4 => "F Durand"
                            5 => "JC Chaput"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1478-3231.2005.01188.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Liver Int"
                        "fecha" => "2006"
                        "volumen" => "26"
                        "paginaInicial" => "46"
                        "paginaFinal" => "54"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16420509"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            29 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "&#91;30&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis&#46; Results of a randomized study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R Planas"
                            1 => "P Gin&#232;s"
                            2 => "V Arroyo"
                            3 => "J Llach"
                            4 => "J Pan&#233;s"
                            5 => "V Vargas"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/0016-5085(90)90481-F"
                      "Revista" => array:6 [
                        "tituloSerie" => "Gastroenterology"
                        "fecha" => "1990"
                        "volumen" => "99"
                        "paginaInicial" => "1736"
                        "paginaFinal" => "1744"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1699835"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            30 => array:3 [
              "identificador" => "bib0031"
              "etiqueta" => "&#91;31&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Repeated paracentesis and i&#46;v&#46; albumin infusion to treat &#8220;tense&#8221; ascites in cirrhotic patients&#46; A safe alternative therapy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "F Salerno"
                            1 => "S Badalamenti"
                            2 => "P Incerti"
                            3 => "S Tempini"
                            4 => "B Restelli"
                            5 => "S Bruno"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0168-8278(87)80067-3"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Hepatol"
                        "fecha" => "1987"
                        "volumen" => "5"
                        "paginaInicial" => "102"
                        "paginaFinal" => "108"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/3655306"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            31 => array:3 [
              "identificador" => "bib0032"
              "etiqueta" => "&#91;32&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Randomized comparative study of hemaccel vs&#46; albumin infusion after total paracentesis in cirrhotic patients with refractory ascites"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "F Salerno"
                            1 => "S Badalamenti"
                            2 => "E Lorenzano"
                            3 => "P Moser"
                            4 => "P&#46; Incerti"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Hepatology"
                        "fecha" => "1991"
                        "volumen" => "13"
                        "paginaInicial" => "707"
                        "paginaFinal" => "713"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1826281"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            32 => array:3 [
              "identificador" => "bib0033"
              "etiqueta" => "&#91;33&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics&#58; a randomized pilot study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "V Singh"
                            1 => "PC Dheerendra"
                            2 => "B Singh"
                            3 => "CK Nain"
                            4 => "D Chawla"
                            5 => "N Sharma"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1572-0241.2008.01787.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Gastroenterol"
                        "fecha" => "2008"
                        "volumen" => "103"
                        "paginaInicial" => "1399"
                        "paginaFinal" => "1405"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18547224"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            33 => array:3 [
              "identificador" => "bib0034"
              "etiqueta" => "&#91;34&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis&#58; a randomized study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "V Singh"
                            1 => "R Kumar"
                            2 => "CK Nain"
                            3 => "B Singh"
                            4 => "AK&#46; Sharma"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1440-1746.2006.04182.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Gastroenterol Hepatol"
                        "fecha" => "2006"
                        "volumen" => "21"
                        "paginaInicial" => "303"
                        "paginaFinal" => "307"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16460491"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            34 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "&#91;35&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J Sola-Vera"
                            1 => "J Mi&#241;ana"
                            2 => "E Ricart"
                            3 => "M Planella"
                            4 => "B Gonz&#225;lez"
                            5 => "X Torras"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1053/jhep.2003.50169"
                      "Revista" => array:6 [
                        "tituloSerie" => "Hepatology"
                        "fecha" => "2003"
                        "volumen" => "37"
                        "paginaInicial" => "1147"
                        "paginaFinal" => "1153"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12717396"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            35 => array:3 [
              "identificador" => "bib0036"
              "etiqueta" => "&#91;36&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Albumin infusion in patients undergoing large-volume paracentesis&#58; a meta-analysis of randomized trials"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "M Bernardi"
                            1 => "P Caraceni"
                            2 => "RJ Navickis"
                            3 => "MM&#46; Wilkes"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/hep.24786"
                      "Revista" => array:6 [
                        "tituloSerie" => "Hepatology"
                        "fecha" => "2012"
                        "volumen" => "55"
                        "paginaInicial" => "1172"
                        "paginaFinal" => "1181"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22095893"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            36 => array:3 [
              "identificador" => "bib0037"
              "etiqueta" => "&#91;37&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Hyponatremia and mortality among patients on the liver-transplant waiting list"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "WR Kim"
                            1 => "SW Biggins"
                            2 => "WK Kremers"
                            3 => "RH Wiesner"
                            4 => "PS Kamath"
                            5 => "JT Benson"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/nejmoa0801209"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2008"
                        "volumen" => "359"
                        "paginaInicial" => "1018"
                        "paginaFinal" => "1026"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18768945"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            37 => array:3 [
              "identificador" => "bib0038"
              "etiqueta" => "&#91;38&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites&#58; relevance of serum sodium concentration"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M Guevara"
                            1 => "ME Baccaro"
                            2 => "J R&#237;os"
                            3 => "M Mart&#237;n-Llah&#237;"
                            4 => "J Uriz"
                            5 => "LR del Arbol"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1478-3231.2010.02293.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Liver Int"
                        "fecha" => "2010"
                        "volumen" => "30"
                        "paginaInicial" => "1137"
                        "paginaFinal" => "1142"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20602681"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            38 => array:3 [
              "identificador" => "bib0039"
              "etiqueta" => "&#91;39&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "P Sort"
                            1 => "M Navasa"
                            2 => "V Arroyo"
                            3 => "X Aldeguer"
                            4 => "R Planas"
                            5 => "L Ruiz-del-Arbol"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/nejm199908053410603"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "1999"
                        "volumen" => "341"
                        "paginaInicial" => "403"
                        "paginaFinal" => "409"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10432325"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            39 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "&#91;40&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Long-term albumin administration in decompensated cirrhosis &#40;ANSWER&#41;&#58; an open-label randomised trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "P Caraceni"
                            1 => "O Riggio"
                            2 => "P Angeli"
                            3 => "C Alessandria"
                            4 => "S Neri"
                            5 => "FG Foschi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(18)30840-7"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "2018"
                        "volumen" => "391"
                        "paginaInicial" => "2417"
                        "paginaFinal" => "2429"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29861076"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/16652681/000000260000000C/v5_202208200714/S1665268121002465/v5_202208200714/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "77774"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Concise reviews"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/16652681/000000260000000C/v5_202208200714/S1665268121002465/v5_202208200714/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268121002465?idApp=UINPBA00004N"
]

Article information

ISSN: 16652681
Original language: English

DOI:10.1016/j.aohep.2021.100547

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 November	6	0	6
2024 October	41	19	60
2024 September	40	10	50
2024 August	33	13	46
2024 July	59	14	73
2024 June	37	6	43
2024 May	37	12	49
2024 April	56	16	72
2024 March	45	13	58
2024 February	63	37	100
2024 January	67	21	88
2023 December	51	14	65
2023 November	81	31	112
2023 October	93	18	111
2023 September	97	16	113
2023 August	80	12	92
2023 July	92	23	115
2023 June	81	5	86
2023 May	149	17	166
2023 April	127	12	139
2023 March	101	7	108
2023 February	76	9	85
2023 January	68	19	87
2022 December	87	11	98
2022 November	67	21	88
2022 October	67	22	89
2022 September	88	39	127
2022 August	76	12	88
2022 July	65	13	78
2022 June	70	16	86
2022 May	79	18	97
2022 April	55	13	68
2022 March	66	29	95
2022 February	42	21	63
2022 January	41	14	55
2021 December	74	43	117
2021 November	8	25	33
2021 October	16	19	35

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter